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3SUMMARY
Intrinsic differences between naïve and memory CD8+ T-cells affect both quality 
and quantity of cognate antigen response. Cellular immune function and metabolic 
pathways are closely linked. The metabolic repertoire of naïve and memory T-cells remains 
largely unknown.  Here we assessed key metabolic features of human naïve and effector-
memory CD8+ T-cells under basal, metabolic stress, and activating conditions. Basal 
mitochondrial respiration was similar in both subsets.  Memory cells, however, possessed 
more complex, tubular mitochondria, and displayed greater respiratory capacity and 
enhanced fatty acid oxidation.  Basal glycolysis was also comparable in both subsets.  
Memory cells, however, showed an exclusive capacity to rapidly upregulate glycolysis after 
mitochondrial respiration blockage.  In line with this finding, effector memory CD8+ T-cells 
expressed more cytoplasmic GAPDH levels with enhanced activity compared to naïve 
CD8+ T-cells. 
Protective immunologic memory depends on antigen-experienced T-cells that are 
able to: (a) rapidly acquire effector function and (b) expand as secondary effector cells 
(Masopust and Picker, 2012).  The clonal re-expansion of memory cells requires aerobic 
glycolysis (Warburg effect) in order to meet added biosynthetic and energetic demands 
(Vander Heiden et al., 2009).  The metabolic requirements of rapidly responding effector 
memory CD8+ T-cells are unknown.  Here we show that human effector memory CD8+ T-
cells possess the intrinsic ability to upregulate aerobic glycolysis with unexpected rapid 
dynamics.  In contrast to prototypical aerobic switch in activated T-cells, this early phase is 
insensitive to blockage of mTORC1, a known regulator of glucose metabolism in 
proliferating T-cells (Finlay et al., 2012; Fox et al., 2005). CD28 signaling via mTORC2 and
AKT is required to sustain this early increased glycolyis. Importantly, preventing this early 
glycolytic phase by either blocking AKT activity or glucose deprivation, led to an impairment 
of IFN-γ secretion. 
4Therefore, increased metabolic capacities in effector memory CD8+ T-cells promote 
a primed state to immediately support high glycolytic activity upon activation.  This early 
glycolytic phase is prerequisite for immediate effector function and therefore linking 
metabolic features with CD8+ T-cells recall functionality.
Our findings established differential metabolic repertoires between naïve and 
effector-memory CD8+ T-cells, with implications for strategies aiming to therapeutically 
manipulate CD8+ T-cell memory.
5INTRODUCTION
Dynamics of the CD8+ T cell response
During acute viral infection, pathogen-specific naïve CD8+ T-cells become 
activated, followed by their rapid clonal expansion and differentiation into cytotoxic effector 
cells (Haring et al., 2006).  Resolution of infection triggers the contraction of effector cells, 
which is accompanied by the formation of a long-lived memory pool (Cui and Kaech, 2010).
Memory CD8+ T-cells provide a source of quiescent, antigen-experienced cells with high 
proliferative capacity (Geginat et al., 2003; Maus et al., 2004; Veiga-Fernandes et al., 2000)
and a lower activation threshold than naïve cells (Adachi and Davis, 2011; Allam et al., 
2009; Pihlgren et al., 1996) (Figure 1).  These traits allow for a rapid generation of effector 
cells during secondary infection (Harty et al., 2000).  The molecular basis defining T-cell 
memory remains an important unresolved issue in immunology.
Figure 1. Number of antigen 
specific CD8+ T-cells in 
response to infection.
Antigen-specific CD8+ T-cell 
undergo massive expansion 
after an acute infection.  In this 
expansion phase activated 
CD8+ T-cells acquire effector 
function with a subsequent 
differentiation into cytotoxic T 
lymphocytes (CTL).    After 
clearance of the pathogen 90% 
to 95% of the effector T cells 
die during a contraction phase. 
The remaining 5–10% of the 
antigen-specific T-cells become 
the memory population.
picture modified from (Williams 
and Bevan, 2007)
6Memory generation
“Cellular barcoding” revealed that a single naïve CD8+ T-cell can give rise both to 
effector and memory populations (Gerlach et al., 2010; Stemberger et al., 2007), raising the 
question, what influences the effector versus memory decision and in which phase memory 
is generated.  The memory forming process is characterized by an increase of the IL7 
receptor (CD127) and a downregulation of the effector marker KLRG1 (Buentke et al., 
2006; Kaech et al., 2003; Sarkar et al., 2008; Schluns et al., 2000).  The balance between 
the transcription factors T-bet and eomesodermin is coupled with the fate of CD8+ T-cells 
differentiating into effector or memory T-cells (Intlekofer et al., 2005). Various cytokines 
regulate expression of these transcription factors.  The best understood of these is IL-12, 
where during the expansion phase it maintains high T-bet expression and drives effector 
generation (Joshi et al., 2007; Mescher et al., 2006; Pearce and Shen, 2007).  In contrast, 
IL12 also inhibits eomesodermin which is thought to promote effector to memory transition 
(Takemoto et al., 2006).  When inflammation subsides, IL12 levels decrease, promoting 
memory formation via increase of eomesodermin.  Several studies have shown the 
importance of an efficient effector induction as an essential precondition for fully functional 
memory T-cells (Intlekofer et al., 2005; Xiao et al., 2009), however, other have 
demonstrated that memory formation can progress partly independent of effector cell 
differentiation (Joshi et al., 2007).  Despite extensive studies in this area, conflicting 
memory T-cell differentiation models exist, a key difference being which phase of the 
immune response CD8+ memory is generated.
7Memory CD8+ T-cells can be further divided into two main subsets which play 
distinct, but cooperative roles in protection of the host on a secondary challenge (Jameson 
and Masopust, 2009), the central memory (T cm) and the effector memory T-cells (T em) 
(Sallusto et al., 2004).  Central-memory T-cells remain or re-express the lymph node 
homing markers CD62L and chemokine receptor 7 (CCR7).  They are long lived cells that 
have a great potential to proliferate and a high capacity to produce IL2 upon antigen re-
stimulation (Champagne et al., 2001).  Due to their chemokine receptor pattern, central 
memory T-cells are located in secondary lymphoid organs and mainly excluded from non-
lymphoid tissue sites such as skin or mucosa, where most pathogens are encountered.
In contrast, effector-memory (T em) cells lack CD62L and CCR7 expression but 
instead express chemokine receptors associated with homing to inflammatory sites such as 
CCR5 (Figure 2).  This difference in migration pattern distributes effector memory CD8+ T-
cells preferentially within non-lymphoid tissues or recirculating in peripheral blood.  Effector 
memory T-cells are considered to have a more limited lifespan and a decreased 
proliferative potential compared to T cm and are therefore unlikely to significantly contribute 
during secondary clonal expansion (Figure 3).  However, effector memory T-cells contain 
preformed cytotoxic granules to rapidly kill infected cells, and are poised to secrete high 
levels of effector cytokines such as IFN-γ and TNF-α (Hansen et al., 2009; Harari et al., 
2009).  In addition, their anatomical distribution in the non-lymphoid tissue places effector 
memory T-cells at pathogen entry sites where they able to utilize immediate effector 
functions.  In line with this view, mouse studies have demonstrated that adoptively 
transferred CD8+ T em populations provide a greater degree of protection against a variety 
of infectious challenges than T cm, when measured early (within a few days) after 
challenge (Bachmann et al., 2005; Huster et al., 2006; Nolz and Harty, 2011).  However, 
during re-exposure to virulent or chronic infections central memory T-cells are more efficient 
in controlling the pathogen (Nolz and Harty, 2011; Takemoto et al., 2006).  During primary 
infections, when foreign antigen is quickly eliminated, maintenance of T cm is favored over 
8T em (Badovinac et al., 2007; Marzo et al., 2005; Wherry et al., 2003).  More pathogenic 
infections, longer antigen persistence or recurrent antigen exposure (as well as prime-boost 
vaccinations) result in a higher number of T em (Masopust et al., 2006).  Nevertheless, 
differentiation factors that drive the generation of either effector- or central memory CD8+ 
T-cells remain largely unknown.  
Figure 3. Proliferation potential 
and longevity of different CD8+ T-
cell subsets
This simplified chart shows the 
longevity and the proliferation 
potential of naïve, effector and the 
two memory subsets: effector 
memory (Tem) and central memory 
(Tcm). The arrows between the 
subsets indicate the conflicting 
models of lineage differentiation.
chart modified from (Jameson and 
Masopust, 2009)
Figure 2. Differential expression 
markers of central memory (Tcm) 
and effector memory (T em) T-cells
Central memory and effector memory 
CD8+ T-cells have different 
expression patterns of chemokine 
receptors. T cm are characterized by 
expression of the lymphnode homing 
receptors CCR7 and CD62L whereas 
T em lack expression of these 
markers. 
picture modified from (Sallusto et al., 
2004)
9Metabolic changes in the life of a CD8+ T-cell 
Access to sufficient nutrients is one of the most fundamental requirements for a cell 
to function normally in context of their specific function.  This requirement can change 
drastically when a cell is stimulated to grow or proliferate.  Nearly a century ago, Otto 
Warburg observed that cancer cells preferentially metabolized glucose to lactate than 
relying on the more energetically efficient mitochondrial oxidative pathways (Warburg, 
1956).  Studies on T-lymphocyte metabolism demonstrated similar findings.  Whereas 
resting lymphocytes primarily use oxidative phosphorylation, activation leads to a shift 
towards glycolysis (Bental and Deutsch, 1993) (Figure 3).  Since these cells used 
glycolysis in the presence of oxygen, this unique metabolic program was termed aerobic 
glycolysis (Warburg effect).  This finding was surprising at that time since bioenergetically 
such a switch occurs in cases of altered mitochondrial function or in the absence of oxygen.  
A possible explanation for aerobic glycolyis might be a high demand for biomass.  Cancer 
cells and activated T-cells both rapidly proliferate.  Intermediates produced in the glycolytic 
pathway provide building blocks for biosynthesis of amino acids, nucleotides and lipids 
(Vander Heiden et al., 2009).  It should be noted that increased glycolysis among effector 
cells is not only a prerequisite for growth and expansion, but also for acquisition of effector 
function (Cham and Gajewski, 2005a; Greiner et al., 1994; MacDonald, 1977).  Blockade of 
this key metabolic pathway results in the diminution of efficacious CD8+ T-cell activation, 
clonal expansion and maturation (Cham et al., 2008; Macintyre et al., 2011; MacIver et al., 
2011).  In addition to the Warburg effect, CD8+ T-cell activation has been demonstrated to
induce mitochondrial membrane hyper-polarization and to elicit mitochondrial biogenesis 
(D'Souza et al., 2007; Gergely et al., 2002).  Inhibition of mitochondrial respiration 
attenuates CD8+ T-cell responses following viral challenge (Yi et al., 2006).
10
During effector-to-memory transition a reverse 'metabolic switch' occurs, where 
aerobic glycolysis is down modulated, again making OXPHOS the primary energy-
generating pathway in the cell (Pearce et al., 2009).
Figure 3. Metabolic changes in CD8+ T-cells upon activation.
Changes in metabolic signatures complements the functionality of CD8+ T-cells. 
Naïve CD8+ T-cells cells oxidize glucose-derived pyruvate, lipids and amino acids in 
the mitochondria resulting in a high ATP yield. Upon activation, glycolysis, as 
characterized by converting pyruvate to lactate, is increased. Simultaneously lipid 
oxidation is downregulated in order to prioritize biosynthesis over efficient ATP 
production. After the pathogen is cleared, memory formation in T cells is 
characterized by a metabolic switch back to oxidative phosphorylation, which results 
in an increased capacity for efficient energy generation.
picture from (Maciver et al., 2013)
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mTOR integration of costimulatory signals and metabolism
In Drosophila, pathogen-associated molecular patterns (PAMPS) signal via Toll 
receptors, which leads to the production of the antimicrobial protein attacin (Tanji and Ip, 
2005).  In this system, antigen recognition and response are mediated via a single receptor. 
Development of the adaptive immune system with the stochastically rearranged, highly 
specialized antigen receptors made the immune response more complex.  Ligation of the T-
cell receptor (TCR) itself was no longer sufficient to decide what type of response should 
ensue.  Additional instructions to orchestrate the immune response became necessary.  For 
T–cells, accessory signals provides this information (Curtsinger and Mescher, 2010;
Sharpe, 2009).  Sensing the combination of antigenic and inflammatory signals by T-cells is 
crucial for a successful immune response.  TCR stimulation (also referred as “signal1”) on 
naïve CD8+ T-cells without co-stimulation (“signal2”) promotes anergy.  Particularly 
integration of CD28, as a co-stimulatory signal, is important for T-cells (Schwartz, 2003).
Activation induced switch from oxidative phosphorylation to aerobic glycolysis in T-cells is 
also dependent on CD28 signaling (Cham and Gajewski, 2005b; Frauwirth et al., 2002b).
This switch is not thought of as a consequence of T-cell, rather metabolic changes are an 
integral component of T-cell activation (Jones and Thompson, 2007).  T-cells are able 
coordinate stimulatory signals (“signal1” and “signal2”) with diverse additional 
environmental and metabolic cues (“signal3”) through the highly evolutionary conserved 
mTOR pathway (Delgoffe and Powell, 2009; Mills and Jameson, 2009).  Via mTOR 
(mammalian target of rapamycin), T-cells interpret these signals and are either activated or 
anergic, generate CD4+ effectors versus regulatory T-cells and generate CD8+ effectors or 
memory cells.
12
mTOR signaling
mTOR exist in two multiprotein complexes mTORC1 and mTORC2.  In mammals 
mTOR is constituvely expressed and regulated post-translationally.  mTORC1 is sensitive 
to immunosuppressive rapamycin whereas mTORC2 is mainly insensitive.  Generally, 
growth factor or cytokine signaling leads to activation of phosphatidylinositide 3-kinases 
(PI3K) and to the subsequent generation of phosphatidylinositol 3-phosphate, which 
recruits AKT (also known as protein kinase B (PKB) and 3-phosphoinositide-dependent 
protein kinase-1 (PDK1) to the cell membrane.  AKT gets phosphorylated by PDK1 at 
residue Thr308.  Complete activation of AKT also needs phosphorylation at the carboxy-
terminal Ser473 by mTORC2. AKT in turn, initiates the signaling cascade to activate 
mTORC1.  In T-cells the PI3K-AKT-mTOR axis is activated by CD28 and IL2 (Colombetti et 
al., 2006). Additional important cytokine signaling via mTOR are IL7 and IL4 to prevent 
apoptosis in T-cells (Rathmell et al., 2001).  IL12 and IFN-γ promote sustained activation of 
mTORC1 (Rao et al., 2010).  mTORC1 activity is also profoundly regulated by amino acids, 
escpecially leucine (Proud, 2007).  Amino deprivation or using the leucine antagonist N-
acetyl-leucine-amide (NALA) decreased mTORC1 activity and T-cell function (Zheng et al., 
2009).  Working in opposition to the AKT/mTORC1 axis, the AMP-activated kinase (AMPK)
complex promotes catabolic processes that maximize energy generation (Hardie, 2007).
AMPK is activated by a decrease in the cellular ATP/AMP ratio and several other kinases 
including calcium/calmodulin-dependent protein kinase kinase 2 (CaMKK2) (Tamas et al., 
2006).  Targets downstream of mTORC1 are protein S6 kinases (S6Ks) and the 
translational repressor eIF4E-binding proteins (4E-BPs).  Phosphorylation by mTORC1 
promotes translation initiation and protein synthesis (Figure 4).
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Figure 4. Activators of mTOR and its downstream targets.
This highly simplified chart shows mTOR signaling pathways in CD8+ T-cells. 
Immunological environmental cues are in black whereas metabolic inputs are 
indicated in green color. Drugs interfering with the signaling components are 
underlined with a red line. 
scheme modified from (Delgoffe and Powell, 2009)
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mTOR effects on CD4 T cell differentiation
At the metabolic level many is known for CD4+ TH1, TH2, TH17 and regulatory T-
cells (T regs).  Evidence for metabolic differences in these subsets came from studies 
dissecting the role of mTOR in T-cell differentiation.  Treatment with rapamycin, an mTOR 
inhibitor, supressed CD4+ T-cell function and proliferation and promoted the differentiation 
into FOXP3+ T regs (Kopf et al., 2007; Zheng et al., 2007).  In line with these findings, 
inhibiting mTORC1 via activation of AMPK with metformin, also led to an increase in Treg 
numbers (Michalek et al., 2011). Later studies dissected the individual contribution of the 
mTORC1 and mTORC2 complex for differential CD4 T-cell differentiation (Delgoffe et al., 
2011). Taken together, a high mTOR activity in CD4+ T-cells leads to effector (Th1, TH2, 
TH17) differentiation, whereas low mTOR activity favours T reg generation (Figure 5).
mTOR effects on CD8+ T-cell 
In CD8+ T-cells, mTOR facilitates anabolic processes during the expansion phase 
and therefore promote CD8+ effector generation, similar to CD4+ T cells (Intlekofer et al., 
2005). However, effector subset differentiation in CD8+ T-cell is much simpler as compared 
to the CD4+ T-cells.  Only one type of effector CD8+ T-cell is described: the cytotoxic T 
lymphocyte (CTL). Instead, activity of mTOR plays an important role in effector CTL versus 
memory differentiation. Surprisingly, mice that were infected with lymphocytic 
choriomeningits virus (LCMV) and treated with low doses of the mTOR inhibitor rapamycin 
during the expansion phase generated more CD8+ memory cells compared to untreated 
mice (Araki et al., 2009). Another independent study also confirmed this finding. In their 
study, IL12 led to an mTOR dependent upregulation of T-bet. Rapamycin decreased mTOR 
activity and led to a decrease in T-bet and a subsequent upregulation of eomesodermin 
(Rao et al., 2010). An increase in CD8+ T cell memory formation has also been reported by 
treatment with the AMPK activator metformin (Pearce et al., 2009).  Together these studies 
15
show interesting new strategies for modulation of the memory formation via metabolism
(Figure 5).
Figure 5. mTOR activity in the context of anabolic and catabolic processes.
High mTOR activity promotes anabolic processes and effector differentiation in both 
CD4+ and CD8+ T-cell subsets.  This process is accompanied by increase in 
glycolysis and biosynthesis (right side).  Low activity or inhibited mTOR activity leads 
to regulatory T-cell induction in CD4+ T-cells and memory formation in CD8+ T-cells 
(left side). 
picture from (Powell and Delgoffe, 2010)
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THESIS
The importance of metabolic regulation for normal immune function, differentiation 
and memory formation is well understood.  However, despite the growing understanding on 
the interplay between metabolism and immune function, little interest has been put on the 
actual metabolic differences between the different established subsets. Given the fact that 
immune cells have to function in a broad variety of different environmental settings, they 
might also possess distinct metabolic repertoires.  Likely, a T cell in the in the skin has to 
deal with very different nutrient conditions compared to a T cell in peripheral blood.  At the 
site of an ongoing inflammation these differences might be even more pronounced.  
Memory T-cells have traditionally been characterized as metabolically quiescent cells, 
similar to their naïve counterparts.  However, important qualitative differences exist 
between the responsiveness of naïve and memory CD8+ T-cells to activating signals and 
homeostatic cytokines (Cui and Kaech, 2010).  Memory cells are known to have less 
stringent activation requirements (Rogers et al., 2000), are able to expand more rapidly 
following re-exposure to cognate antigen (Wherry et al., 2003) and have an increased 
production of effector molecules such as IFN-γ and TNF-alpha (Slifka and Whitton, 2000)
compared to naïve T cells.  It remains unknown whether these differences point to a 
divergence in the regulation of metabolic pathways between both subsets.  We recently 
demonstrated that effector memory CD8+ T-cells have higher random motility compared to 
naïve CD8+ T-cells and produce more heat (Zenhaeusern et al., 2009), suggesting 
differences in their metabolic phenotype. Therefore we hypothesized that the metabolic 
repertoire is a defining feature of naïve vs. memory CD8+ T-cells.
17
EXPERIMENTAL PROCEDURES
Isolation of peripheral blood mononuclear cells and CD8+ T-cells
Blood samples were obtained from healthy donors after written informed consent.  
Peripheral blood mononuclear cells (PBMC) were isolated using standard density gradient 
centrifugation-protocols (LymphoprepTM, Fresenius Kabi, Oslo, Norway).  CD8+ T-cells 
were either positively selected using MACS beads (Miltenyi Biotec GmbH, Bergisch-
Gladbach, Germany) or negatively selected using the EasySep® Human CD8+ T-cell 
Enrichment Kit (Stemcell Technologies Inc., Vancouver, Canada).
Cell sorting
To isolate naïve and effector memory subsets, positively selected CD8+ T-cells were 
incubated with anti-CCR7 mAb-APC (FABP197, R&D systems Europe, United Kingdom) 
and with anti-CD45RA mAb-PB (clone 2H4, Beckman Coulter, California, USA).  
CCR7+CD45RA+ and CCR7negCD45RAneg subsets were then sorted using the BD 
FACSVantage SE System (BD Bioscience, Mountain View CA, USA).  A representative sort 
is shown in suppl. Figure S1A-1C.  Sorted cells were rested for 3 hours in RPMI 1640 
(Sigma-Aldrich, St. Louis, Missouri, USA), containing 10% human AB serum, 50 U/mL 
penicillin and 50 µg/mL streptomycin (all from Invitrogen, Carlsbad, California, USA), before 
continuing with downstream experiments.
Flow cytometry
For staining, cells were resuspended in FACS buffer (1% bovine serum albumin in PBS) 
and incubated with relevant antibodies for 30 min. in the dark at 4°C.  To probe for 
mitochondrial mass, cells were stained with 100 nM mitotracker green (Invitrogen) and 
further processed according to the manufacturer's instructions.  Data were acquired using a 
FACSCalibur flow cytometer (Becton Dickinson, Mountain View, CA, USA) and analyzed 
using FlowJo 8.8.7 software (Tree Star, Inc., Ashland, OR, USA).
18
Seahorse XF flux analyzer
The XF technology, introduced in 2006, combines an electro-optical instrument with plastic 
cartridges to enable the real-time measurement of cellular bioenergetics in a non-invasive, 
multi-well microplate format. Creating a transient micro-chamber of only 2 µl above the 
plated cells, the machine is able to measure small differences in the partial oxygen 
pressure and pH changes in an unbuffered culture medium. Changes in pH are proportional 
to the amount of lactic acid production and calculated as extracellular acidification rates 
(ECAR, mpH/min). The drop in oxygen partial pressure enables the instrument to calculate 
the oxygen consumption rate (OCR, pmoles/min). Four injection ports allow pharmacologic 
manipulation to interrogate different energetic states of the cells. Originally The XF24 flux 
analyzer was made for adherent cell cultures. Toxicologists, testing mitochondrial affection 
by pharmacological compounds, were the first users of this machine. Later different 
research areas (e.g. neurodegeneration, cancer, cell physiology) showed increasing 
interest in addressing mitochondrial dysregulation and respiratory capacity in various cell 
systems. Immunologists started using the XF technology in 2010 (Capasso et al., 2010)
since the machine was not created to work with suspension cells as T lymphocytes. 
Additional coating of the wells with Cell-Tak (BD Bioscience), which is a bioadhesive 
extracted from the marine mussel Mytilus edulis, enables to use the Seahorse flux analyzer 
on lymphocytes.
Figure 6. Measuring OCR and 
ECAR
The Seahorse XF24 flux analyzer 
is able to detect small decreases 
of pH and partial oxygen pressure 
in a temporally created micro-
chamber. With these values 
oxygen consumption rate (OCR) 
and extracellular acidification rate 
(ECAR) are calculated in real 
time.
picture from Seahorse webinar, 
Seahorsebio webpage
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OCR and ECAR measurements
To assess oxygen consumption rates (OCR, pmol/min) and extracellular acidification rates 
(ECAR, mpH/min) of CD8+ T-cell subsets, the Seahorse XF-24 metabolic extracellular flux 
analyzer was utilized (Seahorse Bioscience®, North Billerica, MA, USA).  Briefly, CD8+ T-
cell subsets were resuspended in serum-free unbuffered RPMI 1640 (Sigma-Aldrich) and 
plated onto Seahorse cell plates (6x10e5 cells/well) coated with Cell-Tak (BD Bioscience) 
to enhance T-cell attachment.  Perturbation profiling of CD8+ T-cell metabolic pathway 
usage was performed by addition of oligomycin (1 µM), DNP (170 µM) and rotenone (1 µM) 
(all compounds from Sigma-Aldrich, St. Louis, Missouri, USA).  Seahorse experiments were 
done using the following assay conditions: (2 min MIX TIME, 2 min WAIT TIME, and 4 to 5 
min MEASURE TIME).  Metabolic parameters were calculated as detailed in Figure S2.
Confocal microscopy
Experiments with live cells were performed using the 3I spinning disk confocal microscope 
(Intelligent Imaging Innovations, Denver CO, USA) with a 100x oil-immersion objective at 
5% CO2 and 37°C (IMCF Facility, Biocenter, University of Basel).  Cells were loaded with 
50 nM 'mitotracker green' (MTG, Invitrogen) and 25 nM tetramethylrhodamine-ethyl-ester-
perchlorate (TMRE, Invitrogen).  Cells were incubated for 30 minutes with both dyes, 
washed and resuspended in fresh media.  Since CD8+ T-cells are non-adherent cells, dye-
loaded T-cells were allowed to settle onto culture slides (Ibidi, Munich, Germany) coated 
with poly-d-lysine for 20-30 minutes before imaging.  Stacked images were then acquired at 
0.5 µm intervals throughout the body of each cell.
Experiments with fixed cells were performed on an LSM 710 confocal microscope (Carl 
Zeiss, Jena, Germany) with a 100x oil-immersion objective.  Fresh-sorted CD8+ T-cells 
subsets were allowed to attach by gravity on culture slides (BD Bioscience) coated with 
poly-d-lysine for 20 minutes.  Attached cells were then fixed with 4% paraformaldehyde and 
permeabilized with 0.1% TritonX-100.  Cells were stained with antibodies against FATP2 
(Proteintech, Chicago IL, USA) and GAPDH (Cell Signaling Technology, Danvers MA, 
20
USA), and labeled with the appropriate secondary antibodies.  Stacked images were then 
collected 0.5 µm intervals.  All images were processed using ImageJ (NIH).
Mitochondrial structural and functional analysis
Quantification of mitochondrial structure was carried out on cells labeled with MTG.  
Extraction of mitochondrial structural parameters was performed using a multi-step image-
processing algorithm.  Briefly, MTG intensities in raw images were enhanced by linear 
contrast stretch, spatially process using a 7x7 top hat filter to isolate mitochondrial objects 
and converted into a binary image by a threshold operation.  Mitochondrial circularity (4π
area/perimeter2), length and form factor (1/circularity) were then calculated using ImageJ 
(NIH, Bethesda MD).  Mitochondrial membrane potential (∆ψm) was calculated as the ratio 
of TMRE to MTG fluorescence intensities.  MTG was included to normalize for 
mitochondrial mass differences between cell populations.
Electron microscopy
Transmission electron microscopy was performed at the Biocenter (University of Basel).  
Cells were sequentially fixed in 3% paraformaldehyde, 0.5% glutaraldehyde and 1% 
osmium tetraoxide, embedded and then cut into 60 nm sections.  Micrographs (27’000x 
magnification) were obtained with a Morgagni 268 (FEI, Hillsboro OR, USA) transmission 
electron microscope operated at 80 kV.  Image J software (NIH, Bethesda, USA) was used 
for measuring mitochondrial length (major axis) and width (minor axis).  To quantify the 
morphology of mitochondria from both CD8+ T-cell subsets, the average aspect ratio was 
calculated (major axis to minor axis), an aspect ratio of 1 indicates a circular mitochondrial 
section.
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Palmitate oxidation assay
To purify CCR7+ and CCR7neg populations, CD8+ T-cells were isolated by negative 
selection and stained with anti-CCR7 mAb-PE (FABP197P, R&D Systems).  To separate 
CCR7+ and CCR7neg fractions, cells were incubated with anti-PE magnetic beads (Miltenyi 
Biotec GmbH), and sorted by positive selection using LD columns.  The purity of CCR7+ 
and CCR7neg cells after column isolation, assessed by flow cytometry, was always >80% 
(Figure S3A-S3C).  Following isolation (using both sorting techniques), purified subsets 
were rested as described earlier. Palmitate oxidation among CD8+ T-cell subsets was 
assessed in unbuffered running media containing RPMI 1640-amino acid and RPMI 1640-
vitamin solution (both from Sigma-Aldrich), supplemented with inorganic salts (according to 
the RPMI 1640 formulation) plus 2 mM glutamine.  Sodium palmitate (P9767, Sigma-
Aldrich) was complexed to fatty acid free BSA (ffBSA) (A6003, Sigma-Aldrich) and cells 
were resuspended in running media supplemented with 100 µM palmitate-ffBSA or (as 
control) 100 µM non-complexed ffBSA.  The OCR of CD8+ T-cell subsets in the 
presence/absence of palmitate were recorded following the Seahorse protocol as described 
above.
Real time PCR
Total RNA was isolated using Trizol reagent (Invitrogen), and cDNA generated by GoScript 
reverse transcription system (Promega, Madison WI, USA).  Real time PCR was performed 
using the Taqman technique (primer/probe sets from Applied Biosystems, Carlsbad CA, 
USA) with the 7900HT Real time PCR system (Applied Biosystems).
22
'In-Seahorse' T-cell activation
To monitor CD8+ T-cell activation inside the extracellular flux analyzer (i.e. in real time), 
αCD3 (clone HIT3a, Biolegend San Diego, CA, USA) and αCD28 (clone CD28.2, 
Biolegend) mAb were directly applied onto plated cells by using the instruments multi-
injection ports.  Different antibody concentrations were utilized according to the experiment. 
The doses for αCD3 and αCD28 are indicated in the figure legends for each experiment.  
Both antibodies were injected at 60 minutes after the experiment was initiated. ECAR and 
OCR of both subsets were recorded for the duration of the experiment (12 h).  Mean 
acidification rates at pre- and post-antibody injection from 0-60 and 200-520 minutes, 
respectively, were used to describe the effects of both antibodies on CD8+ T-cell glycolysis.  
To control for non-specific effects of αCD3 mAb, experiments with isotype control mAb 
(IgG2aκ, Biolegend) were performed.  For glucose-free Seahorse experiments unbuffered 
glucose free RPMI 1640 (Sigma-Aldrich) was used.  For inhibitor experiments, LY294002, 
AKTi 1/2 (both from Sigma-Aldrich) and rapamycin (from Merck KGaA, Damrstadt, 
Deutschland) were injected 30-50 minutes prior to activation.
Immune blotting
Fresh-sorted cells were lysed in RIPA buffer (Thermo Scientific, Rockford IL, USA) and 
protein concentration determined by BCA protein assay kit (Thermo Scientific).  Whole cell 
lysates were ran on 4-20% SDS page gels and transferred to nitrocellulose or PVDF 
membranes.  Membranes were then probed with antibodies against HK1, LDHA, PKM2, 
PKM1/2, phospho-Akt (Thr308), phospho-Akt (S473), 4EBP1, p-4EBP1, and GAPDH (all 
from Cell Signaling Tech.), OGDH (Proteintech) and PDK1 (Abcam, Cambridge, UK).  The 
blots were then stained with the appropriate secondary antibody.  The Odyssey imaging
system (LICOR, Lincoln NE, USA) was used for detection.
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Glucose uptake
Sorted CD8+ T-cell subsets were incubated with a combination of αCD3 and αCD28 mAb 
(as indicated) for 45 minutes in serum free RPMI 1640, in the presence of 50 µM 2-NBDG 
(Invitrogen).  Non-stimulated cells were included as controls.  The cells were then washed, 
and NBDG uptake assessed using a Cyan-ADP Flow Cytometer (Beckman Coulter, Brea,
California, USA).
GAPDH activity
To assess GAPDH activity in CD8+ T-cells, a GAPDH assay kit from Innoprot (Innoprot, 
Zitek-Mintegia, Spain) was utilized. Fresh-sorted naïve and EM cells (5x10e5 cells per 
subset) were processed according to the manufacturer's instructions.
Lactate measurements
Fresh sorted cells were seeded into U-bottom 96-well plates (2.4x10e5 cells/well) in 
glucose free RPMI1640 (Invitrogen). Each well was supplemented with glucose and 
inhibitors as indicated and activated with soluble αCD3 (2 µg/mL) and αCD28 (20 µg/mL) 
mAbs. Non-stimulated cells were included as controls. Lactate levels were measured using 
the Lactate Assay Kit from BioVision (BioVision, Inc., San Francisco, USA).
Proliferation
Sorted cells were labeled with the cell proliferation dye eFluor670 (eBioscience, San Diego, 
CA, USA) at a final concentration of 2.5 µM and seeded into a U-bottom 96 well plate 
(1.7x10e5 cells/well). The plated cells were then activated with αCD3 (2 µg/mL) and αCD28 
(20 µg/mL) mAb in serum free RPMI1640.  AB serum was then added 3h after activation.  
Proliferation was measured 3 days post-activation by flow cytometry.
24
IFN-γ ELISA
Sorted cells were plated into U-bottom 96 well plates (3x10e5 cells/well) using glucose free 
RPMI medium. For kinase inhibitor experiments, cells were cultured in 10 mM glucose then 
treated with LY294002 (10 µM), AKTi 1/2 (10 µM) and rapamycin (20 ng/ml). For glucose 
dependency experiments, plated cells were treated with 10 mM glucose or 10 mM 2-deoxy-
D-glucose (see also Figure 21).  The treated cells were then activated with αCD3 (2 
µg/mL) and αCD28 (20 µg/mL) and AB serum was added 3 hours later. Human IFN-γ
levels were measured in supernatants at 12 hours post-activation using a High Sensitivity 
IFN-γ ELISA kit (eBioscience).
CD69 expression 
Isolated CD8+ T-cells were incubated with anti-CCR7 mAb-APC (FABP197, R&D systems 
Europe, United Kingdom) and with anti-CD45RA mAb-PB (clone 2H4, Beckman Coulter, 
California, USA).  The same culture conditions as for the IFN-γ ELISA have been used.  At 
8 hours post-activation, the cells were stained with anti-CD69 mAb-PE (FN50) and the 
appropriate isotype control mAb (both from ImmunoTools Gmb, Friesoythe, Germany).  By 
gating on the two subpopulations CD69 upregulation has been measured in T naïve and T 
effector memory cells. 
Statistical analysis
Data were assessed using either paired Student t-tests (two-sided) or Man Whitney tests.  
Values of p<0.05 were considered to be statistically significant.  For comparison of 
increases (pre/post) in paired samples a linear regression model was used.
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RESULTS
Naïve and effector memory CD8+ T-cell populations display distinct oxidative 
capacities
Aiming to delineate the metabolic signature of quiescent naïve and antigen-
experienced CD8+ T-cell subsets, fresh isolated cells were sorted into CD45RA+CCR7+ 
(naïve, NV) and CD45RAnegCCR7neg (effector memory, EM) subpopulations (Figure S1A-
S1C).  This sorting strategy has been extensively utilized to investigate functional 
differences between naïve and antigen experienced CD8+ T-cells (Geginat et al., 2003;
Romero et al., 2007; Tomiyama et al., 2002).  The oxygen consumption rate (OCR) of both 
cell populations under basal and chemically induced metabolic stress-conditions was 
measured by utilizing a metabolic extracellular flux analyzer (Figure 7A).  Mitochondrial 
stress was induced by addition of oligomycin (ATP synthase blocker), DNP (mitochondrial 
uncoupler), and rotenone (Complex I inhibitor).  All measurements were made in serum 
free, unbuffered standard RPMI, containing glucose (11 mM) and glutamine (2 mM) as the 
major fuel sources.  The obtained respiratory profile provides basal OCR, ATP-coupled 
respiration, maximal/spare mitochondrial capacity, leak respiration and non-mitochondrial 
respiration (detailed in Figure S2A).
Basal OCR was comparable between naïve and effector memory populations (mean 
NV vs. EM: 50 and 60 pMol/min, respectively, n=6, p=0.33) (Figure 7B).  This indicates that 
in the presence of glucose and glutamine and in the absence of serum, the rate of 
mitochondrial substrate oxidation is comparable between quiescent naïve and effector 
memory CD8+ T-cell subsets.  In agreement with this finding, there was no measurable 
difference in ATP-coupled respiration (mean NV vs. EM: 36 and 48 pMol/min, respectively, 
n=6, p=0.23) (Figure 7C) and leak respiration (mean NV vs. EM: 14 and 12 pMol/min, 
respectively, n=6, p=0.49) (Figure 7D) between naïve and effector memory CD8+ T-cells.  
In addition, there was no significant difference in non-mitochondrial respiration between 
naïve and effector memory CD8+ T-cell 
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Figure 7. Mitochondrial respiration-signature of effector memory vs. naïve CD8+ 
T-cells.
(A) Representative oxygen consumption rate (OCR) graph of human naïve (!) and
effector memory (") CD8+ T-cells cultured in glucose/glutamine containing 
unbuffered RPMI.  The OCR of fresh-sorted CD8+ T-cell subsets was monitored in 
real-time using the Seahorse extracellular flux analyzer under basal conditions, and 
following perturbation of mitochondrial function with oligomycin (ATP synthase 
blocker), DNP (mitochondrial uncoupler), and rotenone (Complex I inhibitor).
(B-G) Key respiratory parameters were calculated following perturbation of 
mitochondrial function with oligomycin, DNP, and rotenone.  Graphs show basal 
respiration (B), ATP-coupled respiration (C), leak respiration (D), non-mitochondrial 
respiration (E), maximal respiratory capacity (F), and spare respiratory capacity (G) of 
naïve (!) and effector memory (") CD8+ T-cells.  Pooled paired data and mean 
values from 6 independent experiments/donors are shown. ** indicates p=0.006, 
*** indicates p<0.001 (paired Student t-test).
See also supplementary Figure S1A-S1C, S2A
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subsets (mean NV vs. EM: 14 and 15 pMol/min, respectively, n=6, p=0.68) (Figure 7E).  
Maximal respiratory capacity, however, was consistently increased in effector memory 
CD8+ T-cells compared to naïve cells  (mean NV vs. EM: 160 and 243 pMol/min, 
respectively, n=6, p=0.006) (Figure 7F).  This increased respiratory capacity was only 
observed following uncoupling of mitochondrial proton motive force with DNP, signifying 
that effector memory CD8+ T-cells possess a higher spare respiratory capacity (SRC) than 
naïve cells (mean NV vs. EM: 111 vs. 183 pMol/min, respectively, n=6, p<0.001) (Figure 
7G).  In agreement with this finding, an increased SRC has recently been described as a 
key component of murine CD8+ T-cell memory formation (van der Windt et al., 2012).
Differences in ATP turnover could explain the disparity in mitochondrial respiratory capacity 
between CD8+ T-cell subsets (Zenhaeusern et al., 2009).  Using the above parameters, we 
calculated the cellular respiratory control (CRC) ratio, which is an estimate of mitochondrial 
functionality independent of ATP turnover (Brand and Nicholls, 2011).  It is the ratio of the 
uncoupled respiratory rate [state 3U, OCRpeak-DNP] and the respiratory rate following addition 
of oligomycin [state 4O, OCRoligomycin].  Effector memory CD8+ T-cells displayed a higher 
CRC ratio than naïve cells (mean NV vs. EM: 12 and 21, n=6, p=0.049), indicating that the 
observed difference in respiratory capacity is independent of the rate of ATP utilization by 
both subsets.
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Naïve and memory CD8+ T-cells display disparate mitochondrial phenotypes
Higher maximal respiratory capacity among memory CD8+ T-cells suggests that 
mitochondrial biogenesis is a requirement for cells differentiating from a naïve to a memory
phenotype.  Congruent with the increased SRC, mitochondrial mass of murine memory T-
cells were recently shown to be greater than that of their naïve counterparts (van der Windt 
et al., 2012).  Comparing the mean fluorescence intensity of naïve and effector memory
CD8+ T-cells loaded with the non-voltage dependent fluorescent mitochondrial dye 
mitotracker green (MTG), we also observed higher mitochondrial mass in human effector 
memory CD8+ T-cells (Figure 8A).  Interestingly, effector memory cells consisted of two 
distinct populations, MTGdim and MTGbright, whereas naïve cells were primarily MTGdim.
Next, we characterized the morphology of mitochondria in naïve and effector memory CD8+ 
T-cell subsets.  Fresh-sorted naïve and effector memory CD8+ T-cells were loaded with 
MTG, and mitochondrial morphology assessed by live-cell confocal microscopy. Images 
were then processed by well-established spatial filtering techniques (Hom et al., 2011;
Koopman et al., 2006).  Effector memory CD8+ T-cells were consistently found to possess 
mitochondria that were tubular in morphology, whereas naïve CD8+ T-cells had shorter, 
fragmented mitochondria (Figure 8B).  Morphometric quantification demonstrated that 
mitochondria with longer branch length are present at higher frequency in effector memory 
CD8+ T-cells than in naïve counterparts (median mitochondrial branch length of NV vs. EM: 
0.88 vs. 1.07 µm, respectively, p<0.0001) (Figure 8C).  Additionally, mitochondria with an 
increased 'form factor' (a measure of mitochondrial complexity) (Hom et al., 2011), were 
detected at higher frequency in effector memory CD8+ T-cell than in naïve cells, indicating 
that mitochondria in effector memory cells are more interconnected than their naïve 
counterparts (mean 'form factor' of NV vs. EM: 1.2 and 1.4, respectively, p=0.005) (Figure 
8D). CD8+ T-cell mitochondrial morphology was further assessed by transmission electron 
microscopy.  Mitochondria in naïve CD8+ T-cells were predominantly short, bean shaped 
with sparse cristae connectivity and an expanded 
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Figure 8. Mitochondrial mass and morphology of effector memory vs. naïve 
CD8+ T-cells.
(A) Histogram comparing 'mitotracker green' (MTG)-loaded naïve and effector 
memory CD8+ T-cells (representative of n=3 independently assessed donors).  Filled 
gray histogram shows unstained control.
(B) Stacked confocal microscopy images of MTG loaded naïve and effector memory 
CD8+ T-cells.  Live cell images were collected by spinning disk confocal microscopy 
using the Z-stack function of the microscope (24 sections, 0.5 µm between sections) 
and processed for morphometric analysis.  Magnification = x100, scale bars = 3 µm.
(C, D) Measurements of mitochondrial length (C) and 'form factor' (D) among naïve 
and effector memory CD8+ T-cells.  Both parameters were quantified from 
morphometrically processed live cell images.  One of three independent experiments 
is shown, with 20-40 cells analyzed per experiment.  Data are depicted as scatter 
plots.  ** indicates p=0.005, *** indicates p<0.0001 (Mann-Whitney test).
(E) Transmission electron micrographs (magnification = x28'000) of naïve and effector 
memory CD8+ T-cells.  Yellow squares in the top panel mark inset images shown in 
the bottom panel.  Scale bars = 1000 nm (top), 500 nm (bottom).
(F) Summary of mitochondrial aspect ratio (length of major axis to minor axis) derived 
from transmission electron micrographs.  1 of 3 independent experiments is shown, 
with 10 cells analyzed per experiment.  Data are depicted as scatter plots.  
*** indicates p=0.0001 (Mann-Whitney test).
(G) Immunoblot analysis of oxoglutarate dehydrogenase (OGDH) expression among 
naïve and effector memory CD8+ T-cells.  Actin was used as loading control.  Results 
from 2 of 3 independently assessed donors are shown.
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matrix volume (Figure 8E, left panels).  In contrast, mitochondria in effector memory CD8+ 
T-cells had long, ribbon like mitochondria with more laminated cristae and more compact 
matrix volume (Figure 8E, right panels).  Morphometric analyses of electron microscopy 
images (aspect ratio= major axis to minor axis length) also captured disparities in the 
morphology of mitochondria between naïve and effector memory CD8+ T-cells.  Similar to 
the finding above, mitochondria of effector memory CD8+ T-cells displayed longer, tubular 
mitochondria, whereas mitochondria of naïve cells had a more rounded morphology (mean 
aspect ratio of N vs. EM: 1.6 and 2.5, respectively, p=0.0001) (Figure 8F).
Given the difference in mitochondrial mass between CD8+ T-cell subsets, we 
probed for the expression of oxoglutarate dehydrogenase (OGDH), a key enzyme in the 
Kreb’s cycle, as a marker for differences in mitochondrial content.  In keeping with the 
functional and mass differences described above, OGDH protein was expressed at higher 
levels in effector memory CD8+ T-cells (Figure 8G).
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Lastly, we probed for the functio nal status of CD8+ T-cell mitochondria by 
measuring the mitochondrial membrane potential (∆ψm) of both subsets via live-cell 
imaging.  Fresh-sorted cells were loaded with TMRE (a voltage dependent dye) and MTG, 
and mitochondrial membrane potential was calculated using the fluorescence intensity ratio 
of both dyes (TMRE to MTG) (Figure 9A).  MTG was utilized to correct for differences in 
mitochondrial mass between cell types (Hom et al., 2011).  Mitochondrial membrane 
potential was lower in naïve CD8+ T-cells compared to effector memory counterparts 
(Figure 9B), indicating, that in addition to mass differences, mitochondria of effector 
memory cells also possess greater functional activity than those of naïve cells. Together 
these results demonstrate that the mitochondrial mass, shape, connectivity and functionality 
are distinct between naïve and effector memory CD8+ T-cells.
Figure 9. Mitochondrial membrane potential of effector memory vs. naïve CD8+ 
T-cells.
(A) Stacked confocal images of MTG and tetramethylrhodamine-ethyl-ester-
perchlorate (TMRE) loaded CD8+ T-cells.  Shown are single channel and merged 
(MER) images of naïve and effector memory cells loaded with both dyes.  
Magnification = x100, scale bars = 3 µm.
(B) Mitochondrial membrane potential of fresh isolated CD8+ T-cells was determined 
by normalizing TMRE intensity to MTG.  One of three independent experiments is 
shown.  The data are depicted as a box and whiskers plot, summarizing data from 
n=44 naïve, and n=25 effector memory CD8+ T-cells.  *** indicates p<0.0001 (Mann-
Whitney test).
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Fatty acid metabolism is enhanced in memory CD8+ T-cells compared to naïve cells
It was previously demonstrated that fatty acid oxidation (FAO) is enhanced in mouse 
CD8+ T-cells during effector to memory differentiation (Pearce et al., 2009).  It is not 
known, however, whether differences in FAO exist between quiescent human naïve and 
memory CD8+ T-cell subsets.  To begin to test for such differences, CD8+ T-cells were 
sorted into CCR7+ and CCR7neg fractions (Figure S3).  This simplified sorting strategy 
yields a CCR7+ population highly enriched for naïve cells, and a CCR7neg effector memory 
population containing both CD45RA re-expressing and CD45RAneg cells.  This strategy was 
used exclusively for FAO experiments in order to minimize time that cells are cultured ex 
vivo.  Oxygen consumption was monitored using an in-house media (glucose free, 
unbuffered) in the presence or absence of palmitate complexed to ffBSA (100 µM).  In the 
presence of palmitate-ffBSA there was a marked increase in the basal OCR of effector 
memory CD8+ T-cells, compared to control cells exposed to ffBSA (mean increase: 18 
pMol/min, n=9, p<0.005, Figure 10A, right panel), whereas only a modest, statistically non-
significant increase in basal OCR was observed in naïve-enriched cells exposed to 
palmitate-ffBSA (mean increase: 3 pMol/min, n=9, p=0.49, Figure 10A, left panel).  A 
paired-ratio analysis of both OCR ratios (OCR palmitate to OCR control) was used to 
compare palmitate induced FAO between quiescent CCR7+ (naïve-enriched) and CCR7neg
effector memory subsets.  The mean OCR ratio was significantly higher in effector memory 
cells (regression test, p=0.007, Figure 10B).  This suggests that, although FAO occurs in 
both quiescent populations, the capacity to utilize fatty acids as a substrate for energy 
metabolism is greater in effector memory CD8+ T-cells.  Under glucose free conditions, 
with glutamine being the primary energy source via glutaminolysis, basal OCR of naïve and 
effector memory T-cells were similar (Figure S4).  Thus, increased FAO by effector 
memory CD8+ T-cells is not related to intrinsic differences in basal energy demands 
between subsets.
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Given these functional differences, we next probed for differences in the expression 
of genes involved in fatty acid metabolism in both cell types using a PCR based array.  
Genes differentially expressed in effector memory CD8+ T-cells compared to naïve CD8+ 
T-cells (Figure S5) were confirmed by real time PCR.  The gene encoding fatty acid 
transporter 2 (FATP2) was most prominently upregulated in effector memory CD8+ T-cells 
(Figure 10C).  FATP2 has two established functions in fatty acid metabolism.  First, it 
enhances the uptake of long chain/very long chain free fatty acids, and second it activates 
free fatty acids via its acyl-CoA synthetase activity (Falcon et al., 2010). We probed for 
FATP2 protein expression by confocal microscopy in both CD8+ T-cell subsets.  In line with 
differential expression at the mRNA level, FATP2 protein expression was greater in effector 
memory than in naïve CD8+ T-cells (Figure 11A and 11B).  Moreover, FATP2 localization 
in naïve CD8+ T-cells was concentrated in small, primarily perinuclear compartments 
Figure 10. Fatty acid oxidation by naïve and effector memory CD8+ T-cells.
(A) Analysis of palmitate induced respiration (fatty acid oxidation) by quiescent CD8+ 
T-cell subsets.  OCR of naïve-enriched (!) and effector memory (") CD8+ T-cells from 
n=9 donors were measured by using the extracellular flux analyzer, culturing cells 
either with fatty acid free BSA (ffBSA) or with 100 µM palmitate-ffBSA.  Data are 
presented as bar graphs ± SD.  ** indicates p=0.004 (paired Student t-test).
(B) Paired ratio analysis of palmitate-induced respiration of naïve(-enriched) (!) and
effector memory (") CD8+ T-cells.  The ratio of 'palmitate OCR' to 'ffBSA OCR' for 
paired subsets was used to compare palmitate oxidation between both populations.  
Data and mean values from n=9 donors are shown.  A generalized linear model was 
used to calculate an interaction p-value between the two variables.  * indicates 
p=0.007.
(C) Relative FATP2 expression between naïve (!) and effector memory (") CD8+ T-
cells.  Both transcripts were normalized to actin mRNA levels (n=3 donors, ±SD).  
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(Figure 11A, panels 1-3), whereas in effector memory CD8+ T-cells localization was in 
larger cytoplasmic compartments (Figure 11B, panels 1-3).  In all, these functional and 
cell-biologic findings suggest that, although FAO is utilized in both subsets, greater built-in 
capacity for FAO is characteristic of effector memory CD8+ T-cells.
Figure 11. FATP2 expression by naïve and effector memory CD8+ T-cells.
(A, B) Stacked confocal microscopy images of (A) naïve and (B) effector memory 
CD8+ T-cells stained with anti-FATP2 mAb (green), counterstained with DAPI (blue; 
nucleus).  Yellow boxes mark inset images shown in A1-3 and B1-3.  Representative 
of n=3 independently assessed donors.  Magnification = x100, scale bars = 3 µm.
See also supplementary Figure S3A-S3C, S4 and S5
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Quiescent naïve and effector memory CD8+ T-cells display distinct glycolytic 
capacities
Mitochondrial respiration is the major ATP source for resting lymphocytes (Plas et 
al., 2002; Rathmell et al., 2000).  How readily aerobic glycolysis can be utilized among 
quiescent naïve and memory CD8+ T-cells is not known.  By measuring the extracellular 
acidification rate (ECAR) at basal conditions and following drug-induced modification of 
mitochondrial respiration (oligomycin, DNP, and rotenone; detailed in Figure S2B), we 
determined the glycolytic potential of naïve and effector memory CD8+ T-cells.  The basal 
ECAR was similar for naïve and effector memory CD8+ T-cells (mean N vs. EM: 0.97 and 
1.58 mpH/min, respectively, n=6, p=0.12) (Figure 12A and 12B).  However, following 
inhibition of mitochondrial respiration, the ECAR of effector memory CD8+ T-cells rapidly 
increased to a mean of 4.73 mpH/min, whereas naïve CD8+ T-cells maintained their 
glycolytic rate at a mean of 1.82 mpH/min (n=6, p=0.009) (Figure 12A, 12C).  The viability 
of both subsets, as determined by 7-AAD staining, was similar following treatment with all 
three compounds (data not shown), indicating that the inability of naïve T-cells to 
upregulate glycolysis is not due to a selective decrease in viability of this subpopulation.
Figure 12. Glycolytic potential of naïve and effector memory CD8+ T-cells.
(A) Representative extracellular acidification rate (ECAR) graph of naïve (!) and
effector memory (") CD8+ T-cells.  The ECAR of fresh-sorted CD8+ T-cell subsets 
was monitored in glucose/glutamine containing media.
(B, C) ECAR of naïve and effector memory cells were assessed under basal 
conditions (B), and following inhibition of mitochondrial respiration with oligomycin, 
DNP and rotenone (C).  Pooled paired data and mean values from 6 independent 
experiments/donors are shown.  ** indicates p=0.009 (paired Student t-test).
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Regulation of glycolytic activity in naïve and effector memory CD8+ T-cells
We hypothesized that disparate glycolytic capacity of naïve vs. effector memory 
CD8+ T-cells following activation could be related to either differential availability of 
enzymes involved in glycolytic flux and/or a subset-specific capacity to increase glucose 
uptake following activation.  To address the former, we probed for the expression of key 
enzymes along the glycolytic pathway by immunoblotting.  Hexokinase 1 (HK1), 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), pyruvate kinase M2 (PKM2), and 
lactate dehydrogenase A (LDHA) were all comparably expressed in naïve and effector 
memory CD8+ T-cells, indicating that the glycolytic machinery is present in both subsets 
(Figure 13A).  To determine whether CD8+ T-cell activation induces early subset specific 
increase in glycolytic enzymes, naïve and effector memory cells were stimulated with αCD3
(10µg/mL) and αCD28 (20µg/mL) mAb for 3 hours, and enzyme expression-levels were 
again assessed by immunoblotting.  GAPDH, LDHA, HK1, PKM1/2, and PKM2 expression 
levels remained similar under non-stimulated and stimulated conditions, indicating that the 
observed increase in glycolysis is not due to upregulation of these enzymes (Figure S7).  
Glucose metabolism is a net product of glycolytic and gluconeogenic pathway activity.  
Therefore, transcript levels of fructose-1,6-bisphosphatase-1 (FBP1), a key enzyme of 
gluconeogenesis, were also assessed.  Intriguingly, transcripts of FBP1 were markedly 
reduced in effector memory CD8+ T-cells (Figure 13B).  This finding suggests that glucose 
flux in naïve cells can be shunted from fructose 1,6 bisphosphate back to fructose 6-
phosphate, thus decreasing net glucose utilization along the glycolytic pathway.
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Given that key glycolytic enzymes were present at similar levels in naïve and 
effector memory CD8+ T-cells, we reasoned that intracellular localization could impact
enzyme availability.  Intracellular distribution of GAPDH was assessed due to its recently 
determined nuclear functions, in addition to its well-established metabolic role to catalyzes 
the conversion of glyceraldehyde 3-phosphate to glycerate 1, 3-bisphosphate in the 
cytoplasm (Mazzola and Sirover, 2003).  Intriguingly, in naïve CD8+ T-cells GAPDH was 
predominantly localized in the nucleus (Figure 13C, upper panel).  By contrast, GAPDH 
was detected both in the nucleus and the cytoplasm of effector memory CD8+ T-cells 
(Figure 13C, lower panel).  Despite the observed similarities in protein expression levels, 
enhanced cytoplasmic expression of GAPDH may contribute to increased aerobic 
glycolysis in effector memory CD8+ T-cells immediately after TCR and CD28 ligation.
Figure 13. Key enzymes of the glycolytic machinery in naïve and effector 
memory CD8+ T-cells.
(A) Immunoblot analysis of key glyocolytic enzymes, using whole cell lysate of fresh-
sorted naïve and effector memory CD8+ T-cells.  Actin served as the loading control.  
Results from 2 of 4 independently assessed donors are shown.  
(B) Relative FBP1 mRNA expression between naïve and effector memory CD8+ T-
cells.  Both transcripts were normalized to actin mRNA levels (n=7 donors, ±SD).  
(C) Stacked confocal microscopy images of naïve and effector memory CD8+ T-cells 
stained with anti-GAPDH mAb (red), counterstained with DAPI (blue; nucleus).  
Representative of n=3 independently assessed donors.  Magnification = x100, scale 
bars = 3 µm.
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Cytoplasmic GAPDH has been shown to possess higher glycolytic activity than 
GAPDH compartmentalized in the nucleus (Mazzola and Sirover, 2003).  Hence against 
this background, GAPDH functional capacity was compared between naïve and effector 
memory CD8+ T-cells. In line with the distribution-pattern, GAPDH functional activity was 
consistently higher among effector memory CD8+ T-cells (Figure 14A).  Availability and 
functional capacity of GAPDH thus plausibly supports the enhanced glycolytic activity 
observed among effector memory CD8+ T-cells. 
Figure 14. GAPDH activity in naïve and effector memory CD8+ T-cells.
GAPDH activity is higher in freshly sorted effector memory (") CD8+ T-cells T-cells 
compared to naïve naïve (!) CD8+ T-cells. *** indicates p=0.0009 (paired student t-
test).
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Activation induced glycolysis is intrinsic to effector memory CD8+ T-cells
The ability to upregulate aerobic glycolysis is critical for expansion and maturation of 
effector CD8+ T-cells (Fox et al., 2005).  We therefore assessed the glycolytic potential of 
naïve and effector memory cells under activating conditions, as opposed to chemically 
induced metabolic stress.  To evaluate changes in glycolysis following αCD3 and αCD28 
monoclonal antibody (mAb)-stimulation, an 'in-Seahorse' T-cell activation model was 
developed.  In an initial set of experiments, a low (0.2 µg/mL) or high (10 µg/mL) dose of 
αCD3 mAb (clone Hit3a), together with a fixed dose of αCD28 mAb (20 µg/mL, clone 28.2), 
were applied onto plated cells in the metabolic flux analyzer, and real-time changes in 
ECAR were monitored.  Activation of naïve CD8+ T-cells in this setting led to a rapid rise in 
ECAR, irrespective of the concentration of αCD3 mAb applied (Figure 15A and 15B, open 
symbols).  This increase in ECAR, however, was not sustained (Figure 15A and 15B, open
symbols) and eventually returned to pre-activation levels (Figure 15C and 15D).  In 
analogous experiments, activation of effector memory CD8+ T-cells also led to a rapid rise 
in ECAR (Figure 15A and 15B, filled symbols).  In contrast to naïve cells, however, ECAR 
levels of effector memory CD8+ T-cells were maintained at approximately 5 mpH/min, 
irrespective of the concentration of αCD3 mAb used (Figure 15A and 15B, and 15E and 
15F).  
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Figure 15. Glycolytic activity of naïve and effector memory CD8+ T-cells upon 
TCR and CD28 mediated activation.
(A, B) Representative ECAR graphs of naïve (!) and effector memory (") CD8+ T-
cells treated 'in-Seahorse' with αCD3 mAb at either low dose (0.2 µg/mL; A), or high 
dose (10 µg/mL; B), together with a fixed dose of αCD28 mAb (20 µg/mL).  The time-
point of antibody injection is marked with a dashed red line.  Mean ECAR were 
measured pre- and post-antibody injection (boxes).  Note that injection of 2-deoxy-D-
glucose (2-DG) completely and rapidly abolished glycolysis (B).  
(C-F) Mean ECAR values of 'in-Seahorse' CD8+ T-cell activation-experiments.  The 
ECAR of naïve (C, D) and effector memory (E, F) CD8+ T-cells were determined pre-
and post-injection of low dose (C, E) and high dose (D, F) αCD3 mAb plus αCD28 
mAb.  Pooled paired data from n=3 (low dose), and n=6 (high dose) independent 
experiments/donors are shown.  * indicates p=0.03, ** p=0.004 (paired Student t-
test).
See also supplementary Figure S7
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To verify that the rise in ECAR was due to increased glucose utilization we added 2-deoxy-
D-glucose (2-DG) to activated cells at 600 min post-stimulation (Figure 16B).  Injection of 
2-DG completely abolished activation-induced glycolysis in both CD8+ T-cell subsets, 
establishing that the increase in ECAR is due to increased glucose flux along the glycolytic 
pathway (Figure 16B).  There was no significant difference in the OCR of both subsets 
during the post-activation interval probed in these experiments (Figure S7A and S7B).  Of 
note, upon injection of 2-DG at 600 min post-stimulation, elevated OCR levels were 
observed in both subsets (Figure S7C).
We further performed additional “in-Seahorse” T-cell activation experiments with freshly 
isolated bulk CD8+ T-cells in absence of glucose (Figure 17).  As expected CD8+ T-cells in 
the glucose free medium had a lower basal ECAR compared to the cells in complete 
medium and showed unchanged ECAR levels following αCD3 (1 µg/mL) and αCD28 (10 
µg/mL) monoclonal antibody (mAb)-stimulation.
Figure 17. ECAR measurements of bulk CD8+ T-cells in presence and absence 
of glucose.
Representative ECAR graph of bulk CD8+ T-cells treated 'in-Seahorse' with αCD3 
mAb (1 µg/mL) together with αCD28 mAb (10 µg/mL) in a glucose free medium (#)
and glucose (10mM) containing medium ($).
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Lastly, as an independent read-out for glycolytic activity, lactate concentrations were 
measured in the supernatant of non-activated and activated naïve and effector memory 
CD8+ T-cells.  3 hours after activation, in line with the ECAR data, concentrations of lactate 
were higher in the supernatant of both αCD3/CD28 mAb activated T-cell subsets.  As an 
internal control, effector memory CD8+ T-cells being activated in a glucose free medium did 
not produce any lactate (Figure 18A).  In addition, this increase was more pronounced in 
the effector memory subset compared to naïve CD8+ T-cells (Figure 18B).
Figure 18. Lactate concentrations in the supernatant of naïve and effector 
memory CD8+ T-cells upon TCR and CD28 mediated activation.
(A) Activation with the high dose (10 µg/mL) αCD3 mAb in combination with αCD28 
mAb (20 µg/mL,) leads to significant increase of lactate levels in the supernatant 
after 3 hours.  No lactate was detectable in the supernatant of activated effector 
memory (") T cells being in a glucose free medium.  Pooled paired data and mean 
values from 5 independent experiments/donors are shown.  * indicates p=0.045, 
*** p=0.0007 (paired Student t-test).
(B) The ratio of lactate levels “activated” to “non activated” for paired subsets was 
used to compare the increase of lactate production between both populations.  
Data and mean values from n=5 donors are shown. A generalized linear model 
was used to calculate an interaction p-value between the two variables. * indicates 
p=0.003 (linear regression model)
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To exclude the possibility that non-specific binding of αCD3 mAb was responsible 
for the observed increase in ECAR, control experiments were performed using an 
appropriate isotype control mAb in combination with αCD28 mAb.  There was no detectable 
increase in ECAR for both subpopulations following exposure of cells to isotype control 
antibody (Figure 19A). Sustained activation-induced levels in ECAR among effector 
memory, but not naïve CD8+ T-cells indicated that aerobic glycolysis is differentially 
regulated between both subsets.  We next probed the individual contribution of TCR/CD3 
stimulation vs. co-stimulatory (CD28) signaling in mediating this differential effect.  There 
was no observable increase in ECAR when cells were treated with low dose (0.2 µg/mL) 
αCD3 mAb, whereas high dose (10 µg/mL) αCD3 mAb induced a transient increase 
(Figure 19B).  Moreover, stimulation with αCD28 mAb alone (20 µg/mL) did not have any 
effect on ECAR (Figure 19C).  As demonstrated above, the sustained increase in ECAR 
was again only observed among effector memory CD8+ T-cells treated with both αCD3 and 
αCD28 mAb (Figure 19D).  These results indicate that, although CD3 clustering is sufficient 
to briefly activate aerobic glycolysis in effector memory CD8+ T-cells, CD28 signaling is 
critical for a sustained switch to aerobic glycolysis. 
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Figure 19. Sustained glycolytic switch in effector memory CD8+ T-cells needs 
a combined activation of TCR and CD28.
(A) ECAR graph of naïve and effector memory CD8+ T-cells treated 'in-Seahorse'
with isotype control mAb (mIgG2a, control for αCD3 mAb (10 µg/mL)), plus αCD28 
mAb (20 µg/mL).  
(B-D) ECAR graphs of effector memory CD8+ T-cells treated 'in-Seahorse' with low 
(0.2 µg/mL), and high dose (10 µg/mL) αCD3 mAb alone (B), αCD28mAb (20 
µg/mL) alone (C), or αCD3 mAb combined with αCD28 mAb (D).
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Next, we tested whether naïve and effector memory CD8+ T-cells differ in their ability to 
increase glucose uptake. To probe for this, we measured the uptake of NBDG –a
fluorescent glucose analog– by both subsets following stimulation with αCD3 and αCD28 
mAb.  In total naïve CD8+ T-cells, antibody treatment did not induce an increase in NBDG 
uptake (Figure 20A, left panel).  In contrast, NBDG uptake was consistently, although 
moderately, increased in total effector memory CD8+ T-cells following stimulation (Figure 
20A, right panel). When gating on blasting CD8+ T-cell subsets (characterized by increased 
forward scatter [FSC]– Figure 20B), the differential capacity for glucose uptake became 
even more apparent (Figure 20C).  Thus, in addition to potential FBP1-related differences 
in glucose flux and differences in the cytoplasmic availability of GAPDH, a differential 
capacity to support glycolysis from external glucose sources is present between naïve and 
effector memory CD8+ T-cells.
46
Figure 20. Glucose uptake 
by naïve and effector 
memory CD8+ T-cells 
upon TCR and CD28 
mediated activation.
(A) Uptake of NBDG, a 
fluorescent glucose analog, 
by bulk naïve and effector 
memory CD8+ T-cells that 
were either left untreated, or 
activated for 45 minutes with 
10 µg/mL αCD3 mAb and 20 
µg/mL αCD28 mAb.
(B,C) Uptake of NBDG as 
described in (A), gating on 
'blasting' naïve and effector 
memory CD8+ T-cells.  (B)
Inserts show representative 
forward scatter (FSC) 
histograms of naïve and 
effector memory CD8+ T-
cells, with the population 
gated for assessing NBDG 
uptake indicated (C).  Data 
and mean values of 3 
independent 
experiments/donors are 
shown.  * indicates p=0.04 
(paired Student t-test).
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Contribution of the PI3K/AKT/mTOR axis to immediate-early glycolytic switch in 
effecroe memory CD8+ T-cells
CD28 co-stimulation during T-cell activation enhances glucose utilization via 
signaling along the PI3K/AKT/mTORC1 pathway, which leads to increased cell growth and 
proliferation (Frauwirth et al., 2002a).  The signaling events downstream of CD28 critical for 
early increase in glycolysis intrinsic to effector memory CD8+ T-cells are not known.  To 
address this issue, 'in-Seahorse' αCD3/αCD28 activation experiments were carried out 
using effector memory CD8+ T-cells pre-treated with LY294002 (10 µM, PI3K inhibitor), 
AKTi 1/2 (10 µM, AKT inhibitor), and rapamycin (20 ng/mL, mTORC1 inhibitor) (Figure 21).  
Inhibition of PI3K (Figure 22A) and AKT (Figure22B) completely abolished activation 
induced, immediate-early glycolytic phase in effector memory CD8+ T-cells. Intriguingly, 
immediate-early glycolytic phase was refractory to rapamycin treatment (Figure 22C).
Figure 21. Model of CD28 signaling 
along the PI3K/AKT/mTORC1 pathway
48
Figure 22. Glucose uptake by naïve and effector memory CD8+ T-cells upon 
TCR and CD28 mediated activation.
(A-C, left side) Representative ECAR graphs of naïve and effector memory CD8+ T-
cells treated 'in-Seahorse' with αCD3 mAb at (1 µg/mL) together with αCD28 mAb (10 
µg/mL). PI3K, AKT and mTORC1 inhibitors (!) or DMSO control (") have been 
injected to the wells 30-50 min prior to activation. Time-points for injection of the 
inhibitors and activation antibodies are marked with a dashed red line.  Mean ECAR 
were measured pre- and post-antibody injection (boxes).  To calculate the impact of 
each inhibitor a linear regression model was used to compare the paired groups (A-
C, right side).
(A and B) Pretreatment of CD8+ memory T-cells with 10mcM Ly294002 (A) or 
10mcM AKTi 1/2 (B) inhibited early-immediate glycolytic switch significantly (n=3 
each).  *** indicate p<0.0001 (linear regression model)
(C) Injection of 20ng/ml rapamycin did not affect increase in ECAR after activation 
(n=5). 
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mTORC1 is a known regulator of glycolysis in proliferating T-cells (Finlay et al., 
2012; Fox et al., 2005).  Thus, we investigated the effect of rapamycin on the glycolytic 
capacity of both CD8+ T-cell subpopulations after long-term activation (Figure 23A and B).  
Compared to non-stimulated cells, ECAR was enhanced in both naïve (Figure 23A) and 
effector memory (Figure 23B) CD8+ T-cells stimulated for 3 days with αCD3/αCD28 mAbs.  
However, when activated in the presence of rapamycin (20 ng/mL), there was a marked 
reduction in ECAR between both subsets suggesting that the protracted phase of aerobic 
glycolysis is sensitive to mTORC1 inhibition (Figure 23A and B).
Figure 23. Rapamycin inhibits protacted phase of aerobic glycolyis in naïve and 
memory CD8+ T-cells.
Sorted naïve (A) and effector memory (B) CD8+ T-cells have been activated for 3 
days with αCD3 (1 µg/mL) and αCD28 (10 µg/mL) in the presence or absence of 
20ng/ml rapamycin.  Rapamycin decreased the protacted phase of aerobic glycolyis 
in both subsets.  Additional re-stimulation in the seahorse with the same dose had a 
minimal effect on ECAR in both subsets (first dashed red line).  Note that injection of 
2-deoxy-D-glucose (2-DG) rapidly decreased ECAR. 
!
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Effect of CD28 pathway inhibitors on proliferation
Aerobic glycolysis is essential for providing energy and metabolic intermediates in 
highly proliferating cells (Vander Heiden et al., 2009). In the presence of PI3K-, AKT- and
mTORC1-inhibitors, proliferation of effector memory CD8+ T-cells was blocked (Figure 24).  
These results indicate that the PI3K→AKT→mTORC1 pathway is essential for effector 
memory T-cell expansion, potentially via the regulation of aerobic glycolysis in highly 
proliferating CD8+ T-cells.  More importantly, using the metabolic flux analyzer, we 
discriminated two distinct glycolytic phases in effector memory CD8+ T-cells: the 
rapamycin-insensitive immediate-early phase, and the rapamycin-sensitive protracted 
phase which is essential to support CD8+ T-cell proliferation.
Figure 24. Proliferation of effector memory CD8+ T-cells is affected by various 
CD28 pathway inhibitors.
Effector memory CD8+ T-cells were loaded with eFLuor-APC.  Compared to non 
activated control cells (blue shaded) activation (red line) with αCD3 (2µg/mL) and 
αCD28 (20µg/mL) led to a robust proliferation assessed after 3 days in culture (top 
left).  Activation in the presence of all three inhibitor (green shaded) efficiently blocked 
proliferation.  Representative histograms of 3 independent experiments are shown.
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Phosphorylation on Ser473 is critical for immediate-early glycolytic switch 
Abrogation of glycolysis in effector memory CD8+ T-cells pre-treated with LY294002 
and AKTi 1/2 indicates that AKT plays a central role in regulating immediate-early glycolytic 
switch.  AKT activity is dependent on the phosphorylation of two residues: Thr308 and 
Ser473.  AKT-Thr308 is a target of PDK1, and AKT-Ser473 is phosphorylated by mTORC2, 
which allows AKT to act on additional substrates involved in cell metabolism and survival 
(Guertin et al., 2006).  Recently, mTORC2 activity has been shown to be directly activated 
by the PI3K product PtdIns(3,4,5)P3 (Gan et al., 2011).  Thus PI3K could also impact AKT 
activity indirectly by modulating mTORC2 activity.  To investigate a possible role of 
mTORC2 in immediate early glycolytic switch, effector memory CD8+ T-cells were pre-
treated with OSI-027 (1 µM), an mTORC1/C2 inhibitor, and changes in ECAR levels 
following αCD3/αCD28 mAb activation were assayed as above.  Interestingly, inhibition of 
mTORC1/C2 resulted in a non-sustainable increase in ECAR that eventually returned to 
baseline levels (Figure 25A and B).  Analogous to rapamycin, OSI-027 treatment also 
blocked cell proliferation (Figure 25C).  To probe for an effect of OSI-027 on mTORC2 
activity, we compared AKT-S473 and AKT-T308 phosphorylation in activated effector 
memory CD8+ T-cells by immunoblot analyses (Figure 25D).  AKT-T308 and AKT-S473 
phosphorylation was increased in activated effector memory CD8+ T-cells.  Activation of 
effector memory cells in the presence of either rapamycin or OSI-027 maintained pT308 
levels.  However, OSI-027 dramatically reduced pS473 in activated effector memory cells, 
whereas, pS473 was insensitive to rapamycin.  Under identical conditions we also probed 
for phosphorylation of 4EBP1 (Thr37/46), a downstream target of mTORC1 (Laplante and 
Sabatini, 2012), (Figure 25D).  4EBP1 phosphorylation was increased in activated effector 
memory CD8+ T-cells.  Inhibition of mTORC1 activity either with rapamycin or OSI-027 lead 
to reduction of p4EBP1 levels.  The sensitivity of immediate early glycolytic switch to 
mTORC2 inhibition indicates that AKT phosphorylation at Ser-473 is critical for this event 
(Figure 25D and Figure S8).
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Figure 25. Immediate-early glycolytic switch in effector memory CD8+ T-cells is 
dependent on mTORC2 and AKT activity. 
(A and B) Representative ECAR graph (A) and pre-/post-activation mean ECAR 
(n=5) (B) of effector memory CD8+ T-cells pre-treated with control-media/DMSO (")
or 1 µM OSI-027 (!) prior to activation. *** p<0.001 (linear regression model)
(C) Representative histogram of OSI-027 treated EM CD8+ T-cells, similar strategy 
as described in Figure 24.
(D) Immunoblot and quantitative analyses (in arbitrary units) of effector memory 
CD8+ T-cells, 3 hours post αCD3/αCD28 mAb (2 µg/mL and 20 µg/mL) activation 
with or without rapamycin (20 ng/mL) or OSI-027 (1 µM).  Blots were probed for AKT 
pT308 and pS473, total 4EBP1, and phospho-4EBP1. 
See also supplementary Figure S8
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IFN-γ synthesis by effector memory CD8+ T-cells is dependent on glucose
Effector memory CD8+ T-cells contain preformed cytotoxic granules and are able to 
rapidly upregulate cytokines such as IFN-γ and TNF-α.  Interestingly, IFN-γ synthesis of 
effector CD8+ T-cells is intimately linked to glucose metabolism (Cham et al., 2008; Cham 
and Gajewski, 2005a).  Given the rapid upregulation of glycolytic flux in αCD3/αCD28 mAb 
stimulated effector memory CD8+ T-cells, we assessed the role of the immediate-early 
glycolytic phase on CD8+ T-cell activation and elaboration of effector molecules.  
Specifically, we probed for expression of the activation marker CD69, and assessed IFN-γ
production in quiescent and activated naïve and effector memory CD8+ T-cells.  In naïve T-
cells, the frequency of CD69 expressing T-cells increased significantly following activation 
(Figure 26A and B).  By contrast, IFN-γ remained undetectable after 12 hours of 
stimulation (Figure 26C) indicating that IFN-γ synthesis in previously unprimed human 
CD8+ T-cells requires prolonged activation. 
Figure 26. CD69 expression and IFN-γ production of naïve CD8+ T-cells
(A and B) Cell-surface expression of CD69 on naïve CD8+ T-cells was compared 
between αCD3/αCD28 mAb (2 µg/mL and 20 µg/mL) activated and non-activated 
cells (8h incubation) (n=4).  A representative histogram (A) depicts CD69 expression 
on naïve cells cultured under non-activating (blue line) and activating (red line) 
conditions.  Using an isotype control antibody (black shaded) cells were defined as 
CD69 negative or positive.  Activation led to a higher percentage of CD69 positive 
cells compared to non activated naïve CD8+ T-cells (B). ** indicates p=0.007 
(paired Student t-test).
(C) IFN-γ production by naïve CD8+ T-cells was compared between non-activated 
and αCD3/αCD28 mAb (2 µg/mL and 20 µg/mL) activated cells (12h incubation) (n=4)
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Effector memory CD8+ T-cells also upregulated CD69 following activation (Figure 
27A and B).  In contrast to naïve cells, however, IFN-γ production by effector memory 
CD8+ T-cells was elevated at 12 hours post-stimulation (Figure 27C).  To determine the 
role of the AKT→mTORC1 axis in early effector memory CD8+ T-cell activation, cells were 
treated with AKTi 1/2 or rapamycin (as above).  CD69 surface expression remained 
elevated under both treatment conditions, albeit the frequency of CD69+ cells was slightly 
decreased in AKTi 1/2 treated cells (Figure 27B).  Interestingly, AKT inhibition resulted in a 
clear reduction of IFN-γ production by effector memory CD8+ T-cells, whereas rapamycin 
treatment had no impact on early IFN-γ synthesis (Figure 27C).  The dependence of early 
IFN-γ production on AKT suggested that immediate-early glycolytic switch likely plays a role 
in this effector response.  
Figure 27. CD69 expression and IFN-γ production of effector memory CD8+ T-
cells
(A and B) Representative histogram (A) shows CD69 expression on effector memory 
CD8+ T-cells cultured under conditions as mentioned in (Figure 26).  To determine 
the role of the AKT/mTORC1 axis in early activation, effector memory CD8+ T-cells 
were additionally treated (B) with AKTi 1/2 (10 µM) and rapamycin (20ng/mL).
(C) IFN-γ production by effector memory CD8+ T-cells was compared between non-
activated and αCD3/αCD28 mAb activated cells; ± AKTi 1/2 (10 µM); ± rapamycin 
(20ng/mL) (12h incubation) (n=3).
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To directly probe for the dependence of effector memory T-cell CD69 expression 
and IFN-γ production on glucose availability, cells were activated in the presence of 
different gluose concentrations.  In all the experiments that were assessing proliferation, 
CD69 upregulation or IFN-γ production, 10% human serum was always added 3 hours after 
activation.  However, human AB serum contains around 5mM glucose.  Blocking glycolyis 
by adding 2-deoxyglucose (2-DG) circumvent this issue.  Glucose free medium with additon 
of serum was named “low glucose”, containing around 0.5 mM (Figure 28).
Figure 28. Detailed information about glucose availability conditions used in Figure 29 
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The frequency of CD69 positive cells was similar for all three conditions, 
establishing that early effector memory T-cell activation can occur independently of glucose 
availability (Figure 29A).  IFN-γ production remained elevated in the presence of 0.5 mM 
glucose (Figure 29B).  However, upon addition of 2-DG and under glucose-free conditions, 
IFN-γ production was greatly diminished (Figure 29B).  These findings indicate that IFN-γ
recall response in effector memory CD8+ T-cells is highly dependent on immediate-early 
glycolytic capacity.  Moreover, these experiments correlate AKT activity to effector memory
CD8+ T-cell IFN-γ production via mediating an immediate-early glycolytic switch and thus 
increased glucose metabolism.
Figure 29. CD69 upregulation and IFN-γ production of effector memory CD8+ 
T-cells
(A) Cell-surface expression of CD69 on effector memory CD8+ T-cells was 
compared between non-activated and αCD3/αCD28 mAb activated cells in presence 
of low glucose (0.5 mM); glucose + 2DG; or no glucose / no serum (8h incubation) 
(n=4).
(B) IFN-γ production by effector memory CD8+ T-cells was compared between non-
activated and αCD3/αCD28 mAb activated cells in presence of low glucose (0.5 
mM); low glucose + 2DG; or no glucose/no serum (12h incubation) (n=3).
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DISCUSSION
Important qualitative differences exist between naïve and memory CD8+ T-cells in 
their response to cognate antigen (Cui and Kaech, 2010).  During secondary infections, 
memory CD8+ T-cells are able to respond and acquire effector function more rapidly than 
naïve cells.  Numerous reports have described functional and cell surface phenotypic 
differences between naïve and memory CD8+ T-cells.  Relatively few studies, however, 
have investigated the metabolic repertoire –and its impact on cellular functionality– of these 
key CD8+ T-cell populations.  Experiments detailed in this report show that human naïve 
and effector memory CD8+ T-cells possess distinct metabolic signatures.  This was 
demonstrated by differences in mitochondrial respiratory capacities, mitochondrial mass 
and morphology, cellular substrate utilization and glycolytic potential. 
Using the Seahorse extracellular flux analyzer, we characterized the metabolic 
repertoire of human naïve and effector memory CD8+ T-cells.  Drugs affecting 
mitochondrial respiration were used to define differences in glucose and fatty acid 
metabolism in both CD8+ T-cell subsets.  Later, 'in-Seahorse' TCR and CD28 stimulation 
assays were performed to assess, in real-time, the role of these distinct signaling pathways 
in the remodeling of CD8+ T-cell metabolic repertoire.  Several control experiments, such 
as activation in glucose-free medium, addition of glycolysis inhibitors or lactate 
measurements using an independent technique, demonstrated the reliability of the 
Seahorse system to assess metabolic signatures. 
In the first section of the discussion, the focus will be set on steady state differences 
between two CD8+ T-cell subsets.  The impact of metabolic repertoires on activation-
induced changes will be discussed in the second section.  Critical points will be addressed
in the final section. 
58
I.  Metabolic repertoire of naïve and effector memory CD8+ T-cells
The SRC of effector memory CD8+ T-cells was significantly higher than in their 
naïve counterparts.  This respiratory parameter has been implicated in the ability of cells to 
rapidly respond to higher energy demands, and in the control of reactive oxygen species.
In mice, memory CD8+ T-cells have recently been shown to also have higher SRC than 
their naïve counterparts, and the SRC was mechanistically linked to memory differentiation 
(van der Windt et al., 2012).  The parallel finding of increased SRC in both human and 
murine memory CD8+ T-cells indicates that this trait likely reflects an important feature of 
memory CD8+ T-cell functionality.
Congruent with higher SRC in effector memory CD8+ T-cells, an increase in 
mitochondrial mass was also observed in this subpopulation.  Moreover, a consistent 
feature of effector memory CD8+ T-cells was the presence of distinct MTGbright and MTGdim
populations.  Given this observation, it is interesting to note that the mitochondrial mass of 
HIV- and CMV-specific effector memory CD8+ T-cells, from the same donor, were found to 
have a similar mass distribution –with HIV-specific cells possessing higher mitochondrial 
mass than their CMV-specific counterparts (Petrovas et al., 2007).  This suggests that 
metabolic heterogeneity exists amongst effector memory CD8+ T-cells.  It will be interesting 
to assess whether metabolic heterogeneity associates with functional differences in effector 
memory T-cells, as defined by phenotypic markers such as CD27 and CD28 (Romero et al., 
2007).  In addition, effector memory CD8+ T-cells displayed greater mitochondrial length 
and complexity than naïve cells.  Dynamin related protein 1 (DRP1), a mediator of 
mitochondrial fission, is an established and important regulator of T-cell activation (Baixauli 
et al., 2011).  It can be postulated that tubular mitochondria in effector memory CD8+ T-
cells allow for mitochondrial fission to occur more readily, without the prerequisite 
mitochondrial biogenesis-step typically observed following naïve T-cell activation (D'Souza
et al., 2007).  Whether mitochondrial mass and morphology impact the recall response of 
effector memory CD8+ T-cells remains to be elucidated.
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It was previously demonstrated that fatty acid oxidation (FAO) is enhanced in mouse 
CD8+ T-cells during effector to memory differentiation (Pearce et al., 2009).  We were able 
to extend these findings by showing that the same pattern persists in human CD8+ T-cells.  
Effector memory CD8+ T-cells increased oxygen consumption more than naïve CD8+ T-
cells in the presence of palmitate.  In line with this functional difference, FATP2, an 
important transporter for free fatty acids (Falcon et al., 2010), was elevated on both mRNA 
and protein level in effector memory T-cells.
A further defining metabolic feature of memory CD8+ T-cells was their selective, 
digital signaling-like capacity to upregulate aerobic glycolysis.  Protein expression levels of 
key glycolytic enzymes (HK1, GAPDH, PKM1/2, PKM2, and LDHA) were similar in naïve 
and effector memory subsets.  However, enzymatic activity is subject to regulation at 
various levels (e.g. post-translational modifications, oligomerization state of enzymes, 
allosteric regulation, and cellular localization).  Whether the difference in glycolytic capacity 
observed here is due to differential enzymatic regulation remains to be investigated.  
Cellular distribution of GAPDH protein expression was clearly distinct between naïve and 
effector memory CD8+ T-cells.  GAPDH in naïve cells was primarily localized in the 
nucleus.  In contrast, GAPDH expression in effector memory cells was equally detected in 
both nuclear and cytoplasmic compartments.  Cytoplasmic GAPDH has been shown to 
possess higher glycolytic activity than GAPDH compartmentalized in the nucleus (Mazzola 
and Sirover, 2003).  In line with this we show a higher GAPDH activity in effector memory 
CD8+ T-cells, likely contributing to the higher glycolytic capacity observed.  Nucleus-
localized GAPDH, on the other hand, has been shown to mediate the trans-nitrosylation 
and inhibition of Sirtuin 1 (SIRT1), an essential regulator of energy metabolism (Kornberg et 
al., 2010).  Hence, nucleus-localized GAPDH of CD8+ T-cells likely has additional, as yet 
unidentified effects on CD8+ T-cell metabolic regulation.
Gluconeogenic enzymes antagonize strongly exergonic reactions that promote 
glucose flux along the glycolytic pathway.  Among them, FBP1 catalyzes the hydrolysis of 
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fructose-1,6-bisphosphate into fructose-6-phosphate.  Hypermethylation of FBP1 promoter, 
resulting in decreased enzyme expression, has been demonstrated to enhance aerobic 
glycolysis in highly proliferating tumor cells (Liu et al., 2010).  Opposing levels of FBP1 
mRNA in naïve vs. effector memory CD8+ T-cells suggests that differences in the activity of 
glycolysis vs. gluconeogenesis pathways may dictate net glucose flux in CD8+ T-cell 
subpopulations.  Such a mechanism for controlling glucose metabolism would likely result 
in high adaptability to changes in nutrient availability and/or stimulatory conditions.
In all, the steady state metabolic signature of CD8+ T-cell subsets suggests a 
greater adaptability of effector memory cells to different energy sources compared to naïve 
cells.  Increased SRC and FAO, and the ability of effector memory CD8+ T-cells to rapidly 
upregulate aerobic glycolysis indicates that these metabolic parameters likely play a 
significant role in the survival and function of these cells.
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II.  Activation induced glycolysis in effector memory CD8+ T-cells
T-cell activation is primarily dependent on two signals.  Ligation of the TCR/CD3 
complex triggers activation of mitogen activated protein kinase (MAPK) signaling pathways, 
increased intracellular levels of diacylglycerol (DAG) and Ca2+, and activation of the 
transcription factors NFAT and NF-κB (Smith-Garvin et al., 2009).  Co-stimulation through 
CD28 via its ligands CD80 or CD86, on the other hand, leads to activation of the PI3K–AKT 
pathway and upregulation of Glut1 expression (Frauwirth et al., 2002a; Jacobs et al., 2008).
Aerobic glycolysis was stably increased in effector memory CD8+ T-cells following 
stimulation with both αCD3 and αCD28 antibodies, but not in the absence of CD28 ligation.  
Interestingly, the absence of CD28 co-stimulation leads to deficits in memory CD8+ T-cells 
re-expansion due to an inhibition of cell cycle progression (Borowski et al., 2007).
Moreover, mice lacking CD80 and CD86 have previously been demonstrated to be 
important for CD8+ T-cell recall responses (Grujic et al., 2010).  Thus, enhanced glycolytic 
switch in EM cells could play a role in CD8+ T-cell recall response.
The role of CD28 in mediating glucose uptake by increasing GLUT1 expression is 
well established (Jacobs et al., 2008). We also observed enhanced uptake of 2-NBDG, a 
glucose analog, by activated memory cells compared to naïve CD8+ T-cells.  Our data 
indicate that memory CD8+ T-cells rely on CD28 signaling to sustain immediate-early 
metabolic switch to aerobic glycolysis.  Intriguingly, this switch was insensitive to rapamycin 
treatment.  On the other hand fully phosphorylated AKT on both sites, Thr308 and Ser473, 
was required.  AKT-Thr308 is a target of PI3K via PDK1 and AKT-Ser473 is phosphorylated 
by mTORC2.  Pretreatment with either PI3K inhibitor LY294002, mTORC2 inhibitor OSI-
027 or a direct AKT inhibitor AKTi 1/2 blocked the early upregulation of glycolyis efficiently, 
indicating an important role for AKT in mediating this effect.  Although it is well established 
that LY294002 has an off-target inhibitory effect on mTORC1 (Brunn et al., 1996), this off-
target effect can be ruled out as a confounder in these experiments, since rapamycin had 
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no effect on immediate-early glycolytic phase.  Additionally, all the inhibitors efficiently 
blocked proliferation.
However, It should be noted that such a central role for AKT in T-cell metabolism 
and proliferation has been questioned recently (Macintyre et al., 2011).  Due to different 
experimental settings comparisons with our or other studies are difficult.  For proliferation
assays, Macintyre and colleagues activated naïve mouse cells in the presence of αCD3 
and IL2.  Only at day 5 the inhibitors AKT 1/2 or PI3K inhibitor IC87114 were added for the 
remaining 2 days.  However, it has been shown that early administration of PI3K inhibitors 
after activation is required to block proliferation efficiently (Soond et al., 2010).  As a second 
readout, Macintyre and colleagues measured uptake of radioactively labeled glucose.  
Transgenic naïve CD8+ T-cells were activated with the specific gp33 peptide, washed and 
cultured with 20ng/ml IL2 in the presence of AKTi 1/2 (1 mcM).  Addition of AKTi 1/2 did not 
affect glucose uptake in their experiments.  In our experiments, we pretreated human 
memory CD8+ T-cells witch 10 mcM AKTi 1/2.  Therefore several reasons could account 
for the different findings such as the pretreatment dose of AKT 1/2 or IL2 or the absence of 
co-stimulatory signals in their assays.  In addition, primary expansion and acquisition of 
immune function are distinct from a secondary immune response.  Most mouse studies, 
including Macintyre et al was performed in vitro using unprimed mouse T-cells.  Much less 
is known regarding the metabolic requirements of secondary immune responses.  Thus, 
further studies will have to be done to evaluate the importance of AKT for T-cell 
metabolism.
Increased glycolysis after T-cell activation is thought to be important to build 
intermediates that can produce biomass for proliferation (Vander Heiden et al., 2009).  As a 
central regulator of transcription and protein synthesis mTORC1 plays an important role in 
this context (Laplante and Sabatini, 2012).  Our data confirmed the crucial role of mTORC1 
in proliferation.  Rapamycin efficiently blocked the proliferation and glycolytic rates of 
activated naïve and effector memory CD8+ T-cells at day 3 after activation.  Thus, the 
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insensitivity of immediate-early glycolytic switch to rapamycin treatment points to a distinct 
biologic function for the early upregulation of glycolysis in effector memory CD8+ T-cells.  
Protective immunologic memory depends on antigen-experienced T-cells that are 
able to: (a) rapidly acquire effector function and (b) expand as secondary effector cells 
(Masopust and Picker, 2012).  The immediate acquisition of effector function is mediated by 
effector memory T-cells.  Clonal re-expansion, on the other hand, has been assigned to 
central memory T-cells.  Effector memory CD8+ T-cells are heterogeneous ranging from 
tissue resident, migratory, to blood borne populations (Masopust and Picker, 2012).  Tissue 
resident effector memory (T rm) cells are not accessible with conventional isolation 
methods since they are not recirculating in the blood (Bevan, 2011).  Several models of skin 
infection in mice showed the importance of these site based memory cells (Gebhardt et al., 
2009; Jiang et al., 2012). Circulating effector memory T-cells in the blood contain blood 
borne and migratory effector memory T-cells.  Both memory populations are the first 
adaptive immune cells recruited to sites of infection/inflammation.  Effector memory CD8+ 
T-cells have been shown to be important as a first line defense upon re-exposure to 
pathogens that cause acute infections or replicate in non lymphoid tissues (Bachmann et 
al., 2005; Huster et al., 2006; Nolz and Harty, 2011).  Most of these studies compared recall 
responses of effector memory with central memory CD8+ T-cells responses using adoptive 
transfer models.  Rapid effector function of effector memory CD8+ T-cells was needed for 
efficient clearance of the pathogen.  The contribution of central memory CD8+ T-cells came 
later into account, in cases, when infection could not be cleared immediately.  With their 
enhanced proliferation capacity, central memory T-cells offer a reservoir for cytotoxic 
effector cells, however, with delayed kinetics compared to effector memory cells.  Rapid 
CTL generation against Lysteria monocytogenes (Shedlock et al., 2003), vesicular 
stomatitis virus (Andreasen et al., 2000) or influenza (Liu et al., 1997) was dependent on 
CD28 co-stimulation.  Therefore CD28 signaling is important in similar infection models 
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where effector memory CD8+ T-cells provide a better protection than central memory T-
cells.
In our data, CD28 signaling was important to sustain the early glycolytic phase.  
Interestingly, prevention of this early glycolytic phase by either addition of AKT inhibitors or 
glucose deprivation negatively impacted IFN-γ secretion, which is a well documented 
effector cytokine for immune function (Dalton et al., 1993). In this context, it is important to 
differentiate if the early-immediate switch to glycolysis after activation is an exclusive 
feature of effector memory T-cell or whether this is a common ability among all memory 
cells.  In our study, we compared the metabolic signatures of naïve CD8+ T-cells with 
effector memory CD8+ T-cells.  It is well established that memory T-cells have superior 
functional capacities compared to naïve, however, the potential impact metabolism plays in 
the recall response of various memory populations is not yet known.  An important next 
step will be to compare metabolic features between different memory subsets.  
Unfortunately, we have not been able to do this due to technical limitations.  The XF24 flux 
analyzer requires a significant amount of cells to be plated per well and there was 
insufficient central memory T-cells in peripheral blood to perform metabolic measurements 
(see also supplementary FigureS1).  However, further characterization of metabolic 
profiles of memory T-cells with better technologies, such as the XF96 analyzer, will allow us 
to further dissect the underlying biology of the early-glycolytic phase in effector memory T-
cells.
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Glucose availability can modulate immune responses. Recently it has been shown 
that low dose 2-DG treatment (1mM) only inhibited glycolysis slightly but significantly 
impaired in vitro differentiation of Th1, Th2 and Th17 cells and promoted Treg induction.   
Using a transfer model of EAE, pretreatment of the cells with 2-DG significantly reduced the 
ability of TH17 cells to cause EAE (Shi et al., 2011). Low glucose levels are sufficient for 
IFN-γ production.  Effector memory CD8+ T-cells that were activated in glucose free 
medium but supplemented with 10% serum had lower glucose supply compared to cells in 
glucose containing medium.  However, this low glucose concentration of about 0.5 mM was 
enough to promote normal IFN-γ production.  This is in line with earlier studies reporting no 
impairment of survival and only slight impairment of proliferation (48h) with 0.5 mM glucose 
present in the medium (Maciver et al., 2008). Additional treatment with 10 mM 2-DG, 
creating a molar ratio (2-DG/glucose) of 20:1, nearly blocked IFN-γ production compared to 
complete glucose free conditions.  The residual production might occur due to an 
incomplete inhibition of glycolysis since in previous studies 2-DG/glucose ratios of 25:1 
have been required to completely block CTL mediated cytolysis (MacDonald, 1977).
Several findings in our study have been demonstrated earlier in primary CD8+ T-cell 
immune response.  Similar to our data, CD69 upregulation following activation was not 
affected by glucose deprivation (Wang et al., 2011), however, glucose has been shown to 
be important for IFN-γ production in effector T-cells (Cham and Gajewski, 2005a). Our data 
extend this knowledge to human effector memory CD8+ T-cells offering potentially new 
strategies to modulate local recall responses. 
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III. Critical points
The Seahorse XF24 flux analyzer measures small pH changes in the medium.  For 
this reason, all the experiments have to be performed in unbuffered serum free medium. 
The absence of serum might be an important factor influencing the metabolic 
responsiveness of CD8+ T-cells.  Additionally, the metabolic flux analyzer operates at 21% 
oxygen partial pressure as most other in vitro culture systems.  Several studies have 
revealed that oxygen pressure is much lower in lymph nodes and spleen (Caldwell et al., 
2001).  How more physiologic levels of oxygen will impact the metabolic capacities of 
different T-cell subsets is unknown. 
In several described experiments, naïve and effector memory CD8+ T-cells were 
activated with soluble mABs.  When serum was present prior to antibody injection, serum 
significantly blocked CD8+ T-cell activation. Adding the serum 3 hours after activation 
circumvented this problem.  Still, at the moment of activation, no serum was present.  
However, activation in the presence of serum was still achieved by using beads coupled 
with αCD3/CD28.  Since we were interested in the possible impact of early glycolytic switch 
on immune function, we chose to mimic the “in Seahorse” activation conditions as much as 
possible.  
Low glucose levels (0.5 mM) were sufficient to completely restore IFN-γ production.  
To achieve complete glucose deprivation we either used 10 mM 2-DG or activated T-cells 
in the absence of serum.  Both approaches resulted in a complete inhibition of IFN-γ
production but not CD69 upregulation.  A more elegant way to directly address the impact 
of glucose on IFN-γ production is to dialyze out glucose from human AB serum. 
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PERSPECTIVES
Gene expression is not only regulated by transcription factors, but also by 
epigenetic modifications.  Open chromatin allows gene transcription, whereas 
heterochromatin minimizes transcription.  Specific modifications of histones influence the 
actual or potential transcriptional state (Jenuwein and Allis, 2001). Several studies in 
human and mouse T-cells have described genes that were equally expressed in resting 
naïve and memory CD8+ T-cells, upon activation however, transcription was much greater 
in the memory cells compared to activated naïve T-cells.  These genes are poised for 
activation-induced rapid transcription because of their higher histone acetylation (Araki et 
al., 2008; Fann et al., 2006). More importantly, these genes are closely linked to effector 
function, such as IFN-γ or chemokine receptors.  In addition, epigenetic modifications can 
be inherited stably from a cell to its descendants (Fitzpatrick et al., 1999) having the 
potential therefore to transmit memory during homeostatic proliferation.  A second
epigenetic mechanism of gene silencing is DNA methylation (Bird and Wolffe, 1999).  DNA 
is typically methylated on CpG islands.  Interestingly, 70% of gene promoters are 
associated with CpG islands (Saxonov et al., 2006). IFN-γ secretion is critical for the 
immune function of CD8+ T-cells (Dalton et al., 1993). In naïve CD8+ T-cells, several CpG 
sites in the promoter are methylated (Fitzpatrick et al., 1998).  Upon activation, the IFN-γ
promoter is de-methylated and again partly methylated in memory cells (Kersh et al., 2006).
However, upon reactivation the promoter was rapidly de-methylated in effector memory 
CD8+ T-cells resulting in increased IFN-γ production.  Although a DNA de-methylase 
enzyme has not been identified, this rapid de-methylation was independent of proliferation.  
Interestingly, the IL2 promoter was also demethylated after activation in effector T-cells but 
remained demethylated in memory T-cells.  In the same study, the authors also observed 
that memory cells that have been treated with DNA synthesis inhibitors did not affect IFN-γ
transcription as measured by IFN-γ mRNA and protein expression levels.  Interestingly, but 
not discussed in their study, treatment of effector memory CD8+ T-cells with cycloheximide,
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a protein synthesis inhibitor, also affected IFN-γ mRNA levels.  In addition, actinomycin-D, a 
transcription inhibitor only had minimal effects on early IFN-γ production.  Another 
independent study reported similar findings (Cham and Gajewski, 2005a).  In this study, 
glucose availability was important for effector CD8+ T-cells to produce IFN-γ.  Adding 
cycloheximide at early timepoints (2-6h) inhibited IFN-γ transcription, whereas addition at 
later timepoints did not alter IFN-γ mRNA levels.  IL2 transcription was not affected at any 
timepoint.  The authors concluded that, a de novo protein must be produced within the first 
hours after activation for an efficient transcription of IFN-γ.
Our data shows also shows a dependency on glucose for IFN-γ production in 
effector memory T-cells.  The two mechanisms, rapid demethylation of the IFN-γ promoter 
and increased glycolytic flux are potentially linked in memory CD8+ T-cells.  For future 
studies, it will be interesting to address the importance of early-immediate glycolytic phase 
for IL2 production, since the promoter for this cytokine is completely demethylated in the 
effector and memory subset (Kersh et al., 2006) and was less affected by glucose 
deprivation in effector CD8+ T-cells (Cham and Gajewski, 2005a).  In addition, it has to be
evaluated if glucose deprivation affects the rapid demethylation on the IFN-γ promoter.  In 
summary, the primed glycolytic capacity in effector memory cells could potentially be an 
indispensable requirement for transcription of poised genes, such as IFN-γ.
Recent progress in understanding the molecular inter-connectivity between cellular 
metabolic states and epigenetic modifications has revealed mechanisms on how metabolic 
flux can effect gene transcription (Locasale and Cantley, 2011; Lu and Thompson, 2012).
Most chromatin modifying enzymes require cofactors or substrates that are intermediates in 
the metabolic pathways.  As an example, cytosolic acetyl-CoA -the main substrate for 
histone acetylation- comes from citrate that has been exported from the mitochondria via 
ATP-citrate lyase (ACL).  Citrate itself can be produced via glycolysis or glutaminolyis.  
Tracing experiments with C13 labeled glucose in cells with activated Myc have shown that 
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half of the acetyl groups on H4K16 came from glucose-derived acetyl-CoA (Morrish et al. 
2010).  Activated T-cells increase glucose and glutamine uptake simultaneously. This 
increase in glutamine uptake is thought to replenish the citrate that has been used for 
biosynthesis.  In the epigenetic context however, this uptake is also likely to be important 
for transcription regulation.  Highly proliferating cells produce ATP via aerobic glycolyis.
The conversion of pyruvate to lactate is not only regenerating NAD+ needed for continuous 
flux in the glycolytic pathway, but also to generate a positive oxidative redox potential (high 
NAD+/NADH ratio).  Interestingly, NAD+ is an important stimulatory cofactor for the 
deacetylase SIRT1 (Locasale and Cantley, 2011).  Regulation of SIRT1 activity by 
glycolytic flux is potentially another pathway that can control the expression of poised 
effector genes.  Further studies will have to be done to address the importance of metabolic 
flux in the regulation of immune functions.
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SUPPLEMENTAL DATA
Figure S1. Sorting strategy for CD8+ T-cell subpopulations.
(A) Representative dot plot of fresh isolated CD8+ T-cells stained for CD45RA and 
CCR7.  Four CD8+ T-cell subpopulations are identified as follows: naïve (NV, 
CCR7+CD45RA+), central memory (CM, CCR7+CD45RAneg), effector memory 
(EM, CCR7negCD45RAneg) and EMRA (CD45RA re-expressing effector memory, 
CCR7negCD45RA+).  Values represent frequency of total gated events.
(B, C) Representative dot plots of naïve (B) and effector memory (C) CD8+ T-cell 
subsets sorted by FACS (purity always greater than 95%).  Values represent 
frequency of total gated events.
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Figure S2. Diagram of OCR and ECAR profiles generated by the Seahorse 
extracellular flux analyzer.
(A) Representative OCR time course under basal conditions and following 
perturbation of mitochondrial respiration with oligomycin (1 µM), DNP (175 µM) and 
rotenone (1 µM).  Using this perturbation profiling technique, four OCR rates are 
directly measured by the instrument: the non-corrected basal OCR [OCR(basal-nc)], the 
rate following inhibition of ATP synthase [OCR(oligomycin)], the peak rate following 
mitochondrial uncoupling [OCR(peak-DNP)], and the rate following inhibition of 
mitochondrial respiration [OCR(rotenone)].  The following respiratory parameters 
(indicated by red double-ended arrows in the diagram) are calculated using the 
formulas below:
(1) basal respiration = [OCR(basal-nc)] – [OCR(rotenone)]
(2) ATP coupled respiration = [OCR(basal-nc)] – [OCR(oligomycin)]
(3) leak respiration = [OCR(oligomycin)] – [OCR(rotenone)]
(4) maximal respiratory capacity = [OCR(peak-DNP)] – [OCR(rotenone)]
(5) spare respiratory capacity = [OCR(peak-DNP)] – [OCR(basal-nc)]
(6) non-mitochondrial respiration = OCR(rotenone)
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Figure S4. Basal OCR of naïve and effector memory CD8+ T-cells remains 
similar in the absence of glucose.
The basal OCR of naïve (open square) and effector memory (closed squares) CD8+ 
T-cells were determined in glucose free RPMI using the extracellular flux analyzer.  
Sorting and experimental techniques are described in the materials and method 
section.  Data from 4 donors and mean values are shown.
Figure S3. Sorting strategy for CD8+ T-cells used in palmitate oxidation assays.  
(A-C) CD8+ T-cells were sorted according to CCR7 expression as described in the 
materials and methods section.  Representative dot plots of (A) CCR7-PE stained, 
pre-sorted CD8+ T-cells, and post-sorted CCR7+ (B), and CCR7neg (C) fractions are 
shown.  Sort purity of both fractions used in all palmitate oxidation experiments was 
>80%.
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Figure S5. Lipid metabolism gene-expression profiling in naïve and effector 
memory CD8+ T-cells.
To compare lipid metabolism gene expression between naïve and effector memory 
CD8+ T-cells, the Fatty Acid Metabolism PCR Array from SA Bioscience (Qiagen) 
was used according to the manufacturer's protocol.  Total RNA was isolated as 
described in the EXPERIMENTAL PROCEDURES section.  The red and blue lines 
indicate a three-fold increase.  Genes left of the red line are at least three fold higher 
expressed in effector memory cells than in naïve CD8+ T-cells.  Genes located on the 
right of the blue line are down-regulated in the effector memory subset compared to 
the naïve CD8+ T-cells.
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Figure S6. Polyclonal activation does not impact the OCR of naïve and effector 
memory CD8+ T-cells.
(A) OCR time course of naïve (open square) and effector memory (close square) CD8+ 
T-cells following 'in-Seahorse' polyclonal activation.  As described in the material and 
methods section, cells were treated with anti-CD3 and anti-CD28 mAb, and OCR 
measured pre- and post-activation, and following treatment with 2-deoxy D-glucose (2-
DG) (100 mM).
(B, C) Magnified sections (black boxes in Figure S6A) of the OCR profile of both naïve 
and effector memory subpopulations following (B) antibody and (C) 2-DG treatments.  
Anti-CD3 and anti-CD28 mAb injection does not alter the OCR.  Injection of 2-DG leads 
to an immediate decrease in ECAR (Figure 15B), and to a compensatory increase in 
OCR.
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Figure S7. Protein expression of glycolytic enzymes in naïve and effector 
memory CD8+ T-cells remains unchanged after early activation.
Fresh-isolated CD8+ T-cell subsets were activated with αCD3 and αCD28 mAb for 3 
hours.  Whole cell lysates from non-activated and activated cells were then probed for 
HK1, GAPDH, PKM2, PKM1/2 and LDHA expression by immunoblotting.  Actin was 
used as the loading control.  Results from 1 of 2 independently assessed donors are 
shown.
76
Figure S8. Model explaining the different effects of rapamycin and OSI-027 on 
immediate-early glycolytic switch
Phosphorylation of both sites fully activate AKT and promotes glucose uptake (left).  
Rapamycin (20 ng/ml) only blocks mTORC1 and both sites on AKT are still 
phosphorylated upon T-cell activation (middle).  Treatment with OSI-027 efficently 
blocks both mTOR complexes with a consequent reduction of phosphorylation on 
serine 473 (right).  AKT is not fully activated and glucose uptake is decreased. 
!
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